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Abstract
Deep sequencing of mRNAs (RNA-Seq) is now the preferred method for
transcriptome-wide quantification of gene expression. Yet many mRNA isoforms,
such as those eliminated by nonsense-mediated decay (NMD), are inherently
unstable. Thus a significant drawback of steady-state RNA-Seq is that it
provides marginal information on the flux through alternative splicing pathways.
Measurement of such flux necessitates capture of newly made species prior
to mRNA decay. One means to capture nascent mRNAs is affinity purifying
either the exon junction complex (EJC) or activated spliceosomes. Late-stage
spliceosomes deposit the EJC upstream of exon-exon junctions, where it remains
associated until the first round of translation. As most mRNA decay pathways are
translation-dependent, these EJC- or spliceosome-associated, pre-translational
mRNAs should provide an accurate record of the initial population of alternate
mRNA isoforms.
Previous work has analyzed the protein composition and structure of pre-
translational mRNPs in detail. While in the Moore lab, my project has focused
on exploring the diversity of mRNA isoforms contained within these complexes. As
expected, known NMD isoforms are more highly represented in pre-translational
mRNPs than in RNA-Seq libraries. To investigate whether pre-translational
mRNPs contain novel mRNA isoforms, we created a bioinformatics pipeline that
identified thousands of previously unannotated splicing events. Though many
can be attributed to “splicing noise”, others are evolutionarily-conserved events
that produce new AS-NMD isoforms likely involved in maintenance of protein
homeostasis. Several of these occur in genes whose overexpression has been linked
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Living organisms must regulate gene expression. Although much early focus was
placed on regulation at the level of transcription, post-transcriptional regulation
is just as important, particularly in eukaryotic cells. Once transcribed, precur-
sor mRNAs undergo multiple RNA processing pathways throughout their life
cycles. Each of these involves a wide array of protein and RNAs that mediate
post-transcriptional gene expression regulation from mRNA processing to even-
tual cytoplasmic or nuclear decay. Unfortunately, much of this regulation relies
on the production of short-lived transcripts that have been largely skipped by
traditional sequencing and annotation processes. Thus, we need a means of more
comprehensively cataloging the full eukaryotic transcriptome in order to better
understand post-transcriptional gene regulation.
1.1 General mRNA Processing
After transcription, messenger RNAs (mRNAs) must first go through extensive
processing prior to translation. This happens through a series of discrete mRNA
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processing pathways that all involve a multitude of RNA-protein and RNA-RNA
interactions. Many of these contacts have acute affinities for specific RNA se-
quences or features, ensuring the proper advancement of an mRNA through each
step of processing. Below is a summary of these pathways, and their required
RNA and protein components, with a particular focus on pre-mRNA splicing and
the requisite macromolecular complexes (i.e., spliceosome and the exon junction
complex).
1.1.1 Pre-mRNA Splicing
Faithful transcription of the genome produces premature-messenger RNAs (pre-
mRNAs), each a sequence copy of its DNA predecessor before further nuclear
processing. In its initial state, a pre-mRNA contains a combination of intragenic
non-protein-coding regions, called introns, and expressed regions, or exons. Re-
moval of intronic sequences and subsequent ligation of neighboring exons occurs
during a process known as splicing (Figure 1.1). Though depicted here as a sin-
gular event, the average human gene contains nine to ten introns and some even
have more than 100 (Lander et al. 2001). Further, introns comprise the bulk
of a transcribed message, with lengths typically 10 times that of internal exons.
Splicing, therefore, generates significantly shorter mRNA products for much of
the transcriptome. In fact, length discrepancies between viral DNA and cytoplas-
mic mRNA motivated the initial research into the then-unknown step in mRNA
metabolism (Berget et al. 1977). As sequencing methodology was not yet read-
ily available, authors instead observed mRNA-DNA hybrids under an electron
microscope. Disparate regions between the two molecules caused stretches to re-
main unpaired. Free-floating mRNA ends confirmed expected 5′ and 3′ processing,
whereas loops of single-stranded DNA advanced a model of post-transcriptional
mRNA processing via splicing.
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Figure 1.1: Schematic of the splicing cycle including the two steps of splicing and release of the
intron lariat product. Boxes indicate exons; line show introns. Figure adapted from Shcherbakova et
al. 2013. Copyright 2013 Elsevier.
Efficient intron recognition and removal necessitates that a common feature (i.e.,
sequence or structure) exists in every intron given their ubiquity across the genome.
Such features were first identified when authors compared six intron-exon bound-
aries within the chicken ovalbumin gene (Breathnach et al. 1978). Sequence juxta-
position revealed distinct patterns at both 5′ and 3′ extremities, later called “splice
sites.” Though some nucleotides within the splice sites fluctuated, intronic 5′ and
3′ ends invariably coded for G-U and A-G dinucleotides, respectively. Moreover,
splice site sequences appeared to be conserved among the few introns identified at
the time in other species. More recent advances to sequencing methodology has
since made it possible to analyze introns genome-wide. A comparison of thousands
of short introns in five different organisms not only validated initial observations
of the chicken introns, but also highlighted distinct differences between species
(Lim & Burge 2001). In particular, more advanced organisms (e.g., humans) have
less stringent sequence requirements at splice sites (Figure 1.2). This was most
striking at branch points, the internal sequences used to form an intronic lariat
3
structure during splicing (Section 1.1.2). In yeast, branch points have very little
variability and are easily identifiable by sequence alone (Figure 1.2, top middle).
Though computational methods for predicting splice sites a priori have since been
developed (Desmet et al. 2009), the extent of motif degeneracy in human introns
obfuscates the identification of novel introns.
Figure 1.2: Sequence motifs for 5’ (A) and 3’ (C) splice sites or branch points (B) used in five
different species. Letter height signifies the relative abundance of that nucleotide at each position.
Figure from Lim and Burge 2001. Copyright 2001 National Academy of Sciences.
Soon after the discovery of introns, research began to uncover the mechanistic
details behind splicing. Early observations of intron excision in both yeast and
cellular extracts established that splicing proceeds through two transesterifica-
tion reactions (reviewed in Guthrie 1991). The first of these happens when a 2′
hydroxyl at the branch point adenosine residue nucleophilically attacks the phos-
phate residue upstream of the G-U dinucleotide in the 5′ splice site (Moore &
Sharp 1993). Successful completion of this step produces two splicing intermedi-
ates, a free 5′ exon and an intron lariat structure attached to the 3′ exon (Figure
1.1). The second step begins when the new 3′-OH on the 5′ exon attacks the
phosphate following the 3′ A-G dinucleotide (reviewed in Wahl et al. 2009). This
leads to exon-exon ligation and release of the intron lariat structure. In order for
both reactions to occur efficiently, 5′ and 3′ splice sites must be close in spatial
proximity. As such, introns with extensive secondary and/or tertiary structures
possess the ability to splice in cis without the aid of any other factors. The major-
ity of introns, however, lack the necessary conserved sequences to self-splice, and
4
must rely on a host of trans-acting proteins for excision.
1.1.2 Spliceosome Assembly
Initial experiments in cell-free extracts determined that efficient splicing of nu-
clear pre-mRNAs required two additional factors: ATP and an unexpectedly large
complex of proteins (reviewed in Guthrie 1991). The macromolecular complex,
later identified as the spliceosome, is now known to contain five small nuclear
ribonucleoproteins (snRNPs), the Prp19 complex (NTC), and more than 80 asso-
ciated proteins (reviewed in Wahl et al. 2009). Each individual snRNP consists
of a unique non-coding snRNA (U1, U2, U4, U5, or U6) and numerous accessory
proteins. To ensure precise and accurate excision of intronic sequences, both pro-
tein and RNA components of snRNPs bind to the previously described splice sites
and other intronic regions via transient, step-wise interactions (reviewed in Brow
2002; Wahl et al. 2009). As such, the presence or absence of specific snRNPs,
and other complex-specific proteins, defines the discrete stages in the spliceosome
assembly cycle (Figure 1.3). Hereafter follows a stepwise walkthrough of the de
novo formation of the spliceosome on a pre-mRNA.
Assembly of the first spliceosomal complex, known as the early (E) complex, begins
upon U1 snRNP association with a pre-mRNA substrate. Sequences within the
U1 snRNA complement 5′ splice site motifs, and these RNA-RNA interactions
help position the snRNP at the exon-intron boundary (reviewed in Wahl et al.
2009). Due to their short length, however, these contacts alone are insufficient
to maintain association with U1 snRNP. E complex stability, therefore, relies on
further interactions between spliceosomal proteins and the pre-mRNA. Specifically,
SF1/BBP and a U2 snRNP auxiliary protein bind both the branch point and
downstream polypyrimidine tract in this complex. Thus, U1 snRNP binding and
5
subsequent E complex assembly defines both the 5′ and 3′ ends of an intron.
Figure 1.3: Schematic of the spliceosome assembly cycle showing the stepwise composition of
snRNP(s) and RNA within each discrete spliceosomal complex. Based on data available prior to
single molecule observation of the spliceosome (Section 3.2). Figure adapted from Shcherbakova et
al. 2013. Copyright 2013 Elsevier.
The spliceosome transitions to its second stage, the A complex, when U2 snRNA
binds the branch point and displaces the aforementioned E complex proteins (Fig-
ure 1.3). This rearrangement involves a number of accessory proteins, including
two different ATPases, and thus marks the first of many ATP-dependent steps
throughout the assembly cycle (reviewed in Wahl et al. 2009). Furthermore,
much like the E complex, stable A complex formation requires a combination of
RNA-RNA and RNA-protein interactions. Complementary sequences within U2




residue to bulge out prior to the first transesterification reaction (Query et al.
1994). Additional interactions between either U2 snRNA or the intron itself and
various U2 snRNP proteins help support the structural conformation within the
A complex.
Following A complex assembly, the pre-catalytic spliceosome, or B complex, forms
upon recruitment of the U4/U6 and U5 snRNPs, including many accessory pro-
teins (Figure 1.3). These three join the spliceosome as a preassembled complex,
known as the tri-snRNP, after having been pre-processed in an upstream pathway
(reviewed in Wahl et al. 2009). The tri-snRNP starts off as a di-snRNP established
through extensive base-pairing interactions between U4 and U6 snRNAs, and later
combines with the U5 snRNP by means of several protein-protein connections. Ar-
rangement in this way poises the tri-snRNP for entry into the spliceosome, upon
which U6 and U5 snRNAs create RNA-RNA interactions with U2 snRNA and the
pre-mRNA, respectively (Figure 1.5, left). Stability of these interactions requires
a number of associated proteins, particularly Prp19 and the Nineteen Complex.
However, even with these accessory proteins and all five snRNPS, the B complex
remains inactive until further structural and protein rearrangements.
Figure 1.5: Representation of changes in RNA-RNA interactions between pre-mRNA splice site se-
quences and snRNAs within the precatalytic (left) and catalytically active (right) spliceosomes. Figure
from Wahl et al. 2009. Copyright 2009 Elsevier.
The spliceosome continues to be catalytically inactive until the B* complex is
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generated (reviewed in Wahl et al. 2009). Similar to the B complex, various
ATPases facilitate this transformation, specifically by displacing U1 snRNA from
the 5′ splice site. This intronic region is then available to form RNA-RNA con-
tacts with conserved sequences in U6 snRNA once it has been released from U4
snRNA. While in the activated confirmation, additional connections are estab-
lished between U6 and U2 snRNAs to position the branch point near the 5′ splice
site. Such structural rearrangements lead to the first transesterification reaction
(Section 1.1.1), which occurs during the transition from the B* complex into the
C complex. Further conformational changes within the latter complex bring the
5′ and 3′ splice sites in close proximity, causing the second transesterification re-
action (reviewed in Will & Luhrmann 2011). Successful nucleophilic attack in
this reaction results in ligation of the two exons and formation of an intron lariat
RNA (Section 1.1.1). Following this catalytic step, the splicing cycle concludes
with spliceosome disassembly and recycling, and subsequent release of the mature
mRNA and intron lariat products.
1.1.2.1 Alternative Spliceosome Assembly
In the pathway outline above, spliceosome assembly occurs across a single intron,
establishing its 5′ and 3′ boundaries during A complex formation. This is feasible
for short introns, but mammalian introns can span more than a hundred thou-
sand nucleotides (Lander et al. 2001). Internal exons, on the other hand, are
substantially shorter (≤ 150 nt). As such, closely spaced splice sites on either end
of an exon may be recognized first by the splicing machinery, otherwise known as
cross-exon definition (Berget 1995). As with cross-intron spliceosomes, U1 and U2
snRNP binding define the 5′ and 3′ ends of an exon, respectively. The two path-
ways diverge, however, by the way in which the two snRNPs interact (Braun et al.
2018). Whereas cross-intron A complex assembly relies on contacts between U1
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and U2 to promote binding between U2 and the branch point, cross-exon assembly
results from U1 snRNP interactions with splicing factors at a nearby 3′ splice site
that recruit the U2 snRNP. The two pathways converge during subsequent steps
in assembly, which shift the complex to cross-intron interactions and follow the
previously described pathway (Section 1.1.2).
1.1.3 Exon Junction Complex
Even before discovering specific details of the splicing cycle and spliceosome as-
sembly, it was evident in early experiments that this mRNA processing event had
long-term effects on gene expression. Hamer et al. first explored this using a series
of modified viral transcripts containing between zero and two introns (Hamer &
Leder 1979). The mRNA stability of spliced mRNAs drastically increased com-
pared to the intronless control. However these analyses only examined mRNAs
containing introns within the 5′ UTR and/or ORF. In fact, placing introns down-
stream of an early termination codon had the opposite outcome, and led to in-
creased turnover through the nonsense-mediated decay pathway (Section 1.4.1;
Carter et al. 1996). In both studies, completely removing the intron abolished
the impact on mRNA stability, suggesting that productive splicing must leave
behind something more than ligated exons as a record of its history.
To confirm such a potential marker, Luo and Reed analyzed the protein complexes
associated with intronless and intron-containing transcripts (Luo & Reed 1999).
Spliced transcripts traveled slower in native gels due to association with multiple
messenger ribonucleoprotein complexes (mRNPs), none of which bound the un-
spliced controls (Figure 1.6, left). One of the mRNPs was readily identifiable as
the intron complex, whereas the second bound to spliced mRNAs. To determine if
this spliced mRNP was simply lingering spliceosomes, authors examined the com-
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plexes associated with a slower spliced transcript (AdML, Figure 1.6 right). This
revealed different migration rates between the spliceosome and the spliced mRNP,
thus proving that a complex of proteins remained bound to processed transcripts
after the splicing machinery disassembled.
Figure 1.6: Differences in complexes associated with spliced and unspliced (Δi-mRNP) mRNAs on
native gels. Splicing of Ftz pre-mRNAs (left) is more efficient than AdML pre-mRNAs (right), and
the spliceosome is undetectable in this gel. Figure adapted from Luo and Reed 1999. Copyright 1999
National Academy of Sciences.
Research thereafter continued on a pursuit towards identifying the protein(s) com-
ponent(s) of these splicing-dependent mRNPs. Le Hir et al. first isolated the
complex by crosslinking it to a photoreactive modification near the exon-exon
junction of a synthesized transcript (Le Hir, Melissa J. Moore, et al. 2000). Using
two control mRNAs, the authors compared the spliced mRNP to proteins associ-
ated prior to or in the absence of splicing and found several proteins specific to this
complex. Many of these proteins, however, could not be named without further
experimentation (Le Hir, Izaurralde, et al. 2000). Authors co-immunoprecipitated
candidate proteins and analyzed the associated mRNA to confirm their inclusion
in the spliced mRNP. As expected, members of the complex pulled down more
spliced mRNA than an unprocessed control. Furthermore, all complex proteins
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bound the same section of the spliced mRNA, an eight nucleotide region located 24
nucleotides upstream of the exon-exon junction (Figure 1.7), and protected it from
RNase H digestion. Thus, the authors identified a ~335 kD complex consisting of
SRm160, DEK, RNPS1, REF, and Y14.
Figure 1.7: Schematic of the location (-24 nt) and initially proposed composition of the exon junction
complex. Figure from Le Hir, Izaurralde, et al. 2000. Copyright 2000 Wiley.
These initial studies, however, did not identify all of the proteins now known to be
core components of the exon junction complex (EJC). One of these, Magoh, was
later found during a yeast two-hybrid screening of proteins capable of interacting
with Y14 (Kataoka et al. 2001). Supporting its role in the EJC, Magoh prefer-
entially bound spliced mRNAs and protected the same -24 nt region identified by
Le Hir et al. Moreover, Y14 and Magoh distribution after cellular fractionation
demonstrated that these EJC factors were unique in their continued association
with spliced mRNAs in the cytoplasm. Subsequent mass spectrometry analysis
revealed that the cytoplasmic complex of Y14 and Magoh contained a third factor,
eIF4AIII (Chan et al. 2004). The DEAD-box RNA-binding protein behaved simi-
larly to Y14 and Magoh in terms of both its RNA footprint (i.e., 8 nt at -24) and
cellular localization pattern. Following identification of the final factor, MLN51,
a crystal structure of the four EJC core proteins bound to an mRNA mimic was
obtained in 2006 (Andersen et al. 2006).
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1.1.3.1 EJC Recruitment and Assembly
Given the importance of the EJC in both mRNA expression and stability, it was
critical to next understand how and when this complex assembles onto an intron-
containing transcript. To track EJC deposition, mRNAs were first radioactively
labeled at -24 nt upstream of the exon junction, incubated in splicing reactions,
and then digested with multiple RNases (Reichert et al. 2002). Whereas unspliced
pre-mRNAs showed no signs of protection from RNase degradation, the EJC foot-
print appeared on free 5′ exons formed during the first step of splicing (Figure
1.3). Mass spectrometry analysis of both the C complex and final spliced mRNP
confirmed that EJC core proteins, specifically Y14 and Magoh, assemble onto mR-
NAs prior to exon ligation and remain bound long after spliceosome disassembly.
Though this evidence established when the fully-assembled EJC bound mRNAs,
it did not address whether the complex associates with the spliceosome prior to
binding. To answer this question, Merz et al. tested whether the EJC interacted
with the spliceosome in the absence of binding using a pre-mRNA substrate with
a truncated 5′ exon (Merz et al. 2007). Although purified B*/C complexes bound
to this transcript contained the EJC, none of the core proteins remained in the
final spliced mRNP. These results demonstrated that EJC association does not
require an available binding platform because recruitment and assembly happen
as independent events.
In fact, further studies showed that recruitment of individual EJC core proteins oc-
curs through independent interactions with the spliceosome (Figure 1.8). CWC22,
an essential splicing factor, recruits eIF4AII to the spliceosome prior to its asso-
ciation with other EJC components (reviewed in Woodward et al. 2017). Inter-
actions between the two proteins locks the latter into an inactive conformation
until further assembly steps. On the other hand, specifics about Y14 and Magoh
recruitment remain largely unknown. Recent evidence suggests that these factors
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join as a pre-assembled heterodimer, though it is unclear what facilitates its in-
corporation into the spliceosome (reviewed in Woodward et al. 2017). Current
models propose that stable recruitment and deposition of Y14:Magoh potentially
relies on interactions with either eIF4AII or IBP160, a tri-snRNP protein.
After the first step of splicing, the separately recruited proteins assemble into the
EJC while associated with the C complex (Figure 1.8). Assembly initiates when
CWC22 releases eIF4AII, allowing it to change to an active confirmation capable
of binding both ATP and RNA (reviewed in Woodward et al. 2017). The crystal
structure of eIF4AII in this conformational state showed that it binds to the sugar-
phosphate backbone, allowing for precise localization (i.e., 8 nt at -24) of the EJC
independent of mRNA sequence (Andersen et al. 2006). Once in its active state,
the heterodimer then binds to eIF4AII and locks it onto the 5′ exon by blocking
further ATPase activity. Following release from the spliceosome, MLN51, the last
remaining core protein, further stabilizes eIF4AII on the mRNA through contacts
with the surrounding nucleotides.
1.1.3.2 EJC Disassembly and Translation
Once assembled, EJCs continue to bind spliced transcripts through nuclear export
and in the cytoplasm (Figure 1.8). This association is now known to continue un-
til the first, or “pioneer,” round of translation. To investigate the relationship
between the EJC and translation, Dostie and Dreyfuss fractionated cytoplasmic
material across sucrose gradients (Dostie & Dreyfuss 2002). The mRNP and, to
a lesser extent, the monosome fractions both contained Y14, and presumably the
rest of the EJC. However, the complex was missing from the polysome fraction.
The authors further examined the effect of translation by comparing levels of Y14
across a number of modified mRNAs and found enhanced association on transla-
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tionally inactive transcripts. Although these results established that EJC removal
requires active translation, mechanistic details behind this relationship continue
to be investigated. As of now, it has been suggested that removal requires inter-
actions between the EJC and an accessory protein, PYM (reviewed in Woodward
et al. 2017). PYM contacts both the EJC and the translating ribosome through
its N- and C-terminus, respectively, thus connecting the two macromolecular com-
plexes. Interactions with between the ribosome and PYM, however, have been
shown to be dispensable for EJC disassembly in Drosophila. As such, it remains
unclear how PYM functions in vivo.
Figure 1.8: Depiction of the exon junction complex assembly cycle. (i) EJC components are recruited
to the catalytically active spliceosome complex. (ii) Following release from the spliceosome, the EJC
remains stably bound -24 nt upstream of the newly created exon-exon junction. (iii to v) The EJC-
containing mRNP is exported to the cytoplasm where it remains associated until the pioneer round of
translation (vi). EJC components re-enter the nucleus and are recycled for use in subsequent splicing
reactions. Figure from Woodward et al. 2017. Copyright 2017 Wiley.
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1.2 Alternative mRNA Processing
Though the mRNA life cycle has been presented thus far as a series of simpli-
fied linear pathways, numerous alternative processing steps can occur throughout
an mRNA’s existence. Without these, each gene would simply produce a single
transcript that coded for only one protein. Instead multiple mRNAs and proteins
derive from just one gene through a combination of co- and post-transcriptional
mechanisms, including: alternative transcription initiation, alternative splicing,
alternative polyadenylation (APA), and alternative translation initiation.
Not only do these alternative mRNA processing events greatly expand the tran-
scriptome, they also provide multiple opportunities to regulate gene expression.
For example, different APA choices change the length of 3′ UTRs between tran-
scripts. As this region often harbors localization signals, these differences can
greatly modify the localization pattern of a transcript. Furthermore, shorter 3′
UTRs profoundly affect translation efficiency due to decreased interactions be-
tween the polyA tail and initiation factors (Section 1.3.1; reviewed in Klerk &
‘t Hoen 2015). The reduction in translation leads to increased turnover of the
mRNA (Section 1.3.1), thus connecting APA and mRNA stability.
Though the majority of the genome contains APA sites, many are functionally
suppressed and, consequently, largely unanalyzed (reviewed in Klerk & ‘t Hoen
2015). This is not unique, however, to this form of alternative mRNA processing.
As many of these mechanisms significantly alter the half-life of a transcript, evi-
dence of their usage is fleeting. Fortunately, recent advancements in sequencing
technology have provided better ways of exploring the frequency of many alterna-
tive mRNA processing events. For the sake of brevity, the following section will
focus solely on alternative splicing and its ramifications on gene expression.
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1.2.1 Alternative Splicing
The pre-mRNA splicing cycle in Figure 1.1 depicts a simplistic model in which
neighboring exons always join to form the final mRNA product. In fact, this
mRNA processing event is often much more complicated. Alternative splicing (AS)
varies the exonic regions included or excluded when processing each pre-mRNA,
thereby expanding the transcriptome and increasing protein diversity. AS events
fall into one of the following categories, each of which is depicted in Figure 1.9: (a)
alternative 5′ splice site; (b) alternative 3′ splice site; (c) cassette exon - skipping
or inclusion; (d) mutually exclusive exons; and (5) intron retention.
Figure 1.9: Figure 1.4: Major types of alternative splicing: (a) alternative 5′ splice site; (b) alternative
3′ splice site; (c) cassette exon - skipping or inclusion; (d) mutually exclusive exons; and (5) intron
retention. Constitutive exons appear as open boxes, and shaded boxes represent alternative exons.
Lines above and below the depicted pre-mRNA show alternative splicing events. Figure adapted from
Graveley 2001. Copyright 2001 Elsevier.
Similar to the discovery of splicing (Section 1.1.1; Berget et al. 1977), the first
observation of alternative splicing happened during the analysis of various mRNAs
transcribed from the adenovirus genome (Chow et al. 1977; Klessig 1977). None of
the transcripts examined completely hybridized to DNA, which indicated that each
of the viral gene products underwent splicing. The authors confirmed this using
short sequence probes that covered potential exonic regions. However, two mRNAs
expressed late in the viral infection cycle failed this secondary hybridization due
to discontinuous sequence rearrangements. Chow et al. suggested this must result
17
from alternate processing of adenovirus transcripts, but could also happen for
eukaryotic mRNAs. In 1982, Rosenfeld et al. observed such an event in rat thyroid
tumor cells in response to calcitonin starvation (Rosenfeld et al. 1982). Further
analysis revealed that alternative splicing patterns of calcitonin transcripts varied
between neural tissue and thyroidal cells, and suggested this processing event
requires a high level of regulation (Rosenfeld et al. 1983).
Based on these and similar results, AS was initially suspected to be simply a minor
pathway (Stamm et al. 2005), but the prevalence of events grew exponentially as
new methods of analyzing the transcriptome emerged. By the early 2000s, multiple
analyses based on expressed sequence tags revealed that pre-mRNAs from 35 to
60% of all human genes undergo AS during maturation (reviewed in Stamm et al.
2005). This approximation later grew to 74% with the use of DNA microarrays.
These technologies, however, likely underrepresented the true prevalence of AS as
both only analyze a limited portion of each pre-mRNA and/or require a priori
knowledge of its existence. As such, the advent of deep sequencing technology,
which circumvents these limitations, significantly improved the ability to detect
new pre-mRNA species. Consequently, extensive deep sequencing of RNA (RNA-
Seq) has now revealed that more than 95% of human protein-coding genes are
subject to AS (Eric T Wang et al. 2008; Pan et al. 2008).
Although this high percentage shows that almost every pre-mRNA must be pro-
cessed differently by the splicing machinery, it provides little insight into the num-
ber of AS isoforms per gene. Current annotations have now identified ~82,000
different protein-coding mRNA isoforms transcribed from ~20,000 protein coding
genes (Cunningham et al. 2019). Thus, on average, each gene produces approxi-
mately four different mature transcripts. In some cases, however, the amount of
isoforms per gene can reach into the thousands. For example, Drosophila tran-
scribe more than 38,000 isoforms from the Down syndrome cell adhesion molecule
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(DSCAM) gene (Nilsen & Graveley 2010). Although this represents an extreme
case, this gene alone produces more mRNAs than the number of genes in the
fly genome (~14,500) and demonstrates how powerful AS is in diversifying the
transcriptome.
1.2.1.1 Functional Alternative Splicing
Based on initial annotations, the vast majority (~75%) of AS events mapped
within the open reading f rame (ORF) of mRNAs (Stamm et al. 2005). As such,
the functional relevance of each isoform could vary anywhere from a total loss-
of-function to a complete overhaul of an mRNA’s activity and localization. The
former typically results from introducing a premature termination codon into the
ORF, either by including intronic sequences containing a stop codon or by causing
a frameshift that introduces one. These isoforms most often exist as a means of
quickly abolishing further translation of a gene as these transcripts experience
rapid turnover by the NMD pathway (Section 1.4.2).
Unlike the loss-of-function isoforms described above, not all of AS events lead to
negative outcomes. In fact, many exist as a means of modifying protein function
post-transcriptionally. For example, different isoforms of the calcitonin gene not
only have tissue-specific expression patterns (Section 1.2.1), but also serve entirely
different purposes within these particular tissues (reviewed in Stamm et al. 2005).
In the thyroid, full-length calcitonin acts in calcium and phosphorus metabolism,
whereas in the nucleus, the shorter variant known as calcitonin-gene-related pep-
tide (CGRP) functions as a vasodilator. Furthermore, other AS events may excise
entire binding or localization domains, as is the case with interleukin 4 (reviewed
in Stamm et al. 2005). The isoform lacking its transmembrane domain remains
soluble but otherwise fully functional, and soaks up growth hormone binding pro-
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tein in order to regulate the signal transduction pathway of the membrane-bound
form. In addition to these examples, AS can also control post-transcriptional
gene expression by affecting protein and/or mRNA stability, signaling activity,
and post-translational modifications.
1.2.1.2 Unproductive Splicing Events / Splicing Noise
However, the sheer number of transcripts identified by these deeper analyses makes
it implausible for every mRNA in the cell to have functional relevance. As evalu-
ating the biological purpose of each isoform presents an impractical task, authors
have long relied on the lack of conserved splicing patterns to identify aberrant
splicing events, or “splicing noise.” AS events conserved across different species,
particularly those that evolutionarily diverged millions of years ago, likely repre-
sent functionally important transcripts. On the other hand, those lacking function
face no such evolutionary constraint and are not expected to appear in multiple
species. Surprisingly, a comparison of EST-based transcriptomes of mice and hu-
mans revealed that only a small percentage of exon-skipping events were conserved
(Yeo et al. 2005). Subsequent RNA-Seq experiments uncovered a much greater
overlap between the two species and even more so between humans and primates,
but many AS exons continued to be species-specific (Barbosa-Morais et al. 2012).
Thereafter, it next became a question whether these unconserved transcripts had
any functionality within the cell or if they simply resulted from aberrant splicing
events. By examining alternative and constitutive exons transcriptome-wide, Dou
et al. found that alternative 5′ and 3′ splice sites most often occurred within a
few nucleotides of the dominant splice site (Dou et al. 2006). These results sug-
gested that the splicing machinery could use nearby AG/GT dinucleotides during
catalysis. However, further investigations determined that although weak consen-
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sus sequences drove the frequency of alternative splicing events, the spliceosome
acts with a high degree of fidelity (i.e., one error per 100,000 events) (Fox-Walsh
& Hertel 2009). Nonetheless, this study only addressed the error rates of two
genes. Extensive deep sequencing experiments later found a transcriptome-wide
error rate of 0.7%, and that longer intronic regions significantly increased this rate
(Pickrell et al. 2010). In spite of that, the authors acknowledged these rates likely
underestimate the true quantity of splicing noise due to rapid turnover by the
NMD pathway (Sections 1.4.1 and 1.4.1.1). Therefore, the transcriptome must
be evaluated in the absence of this pathway in order to observe the true rate of
splicing noise.
1.2.1.3 Regulating Alternative Splicing Across the Tran-
scriptome
Whereas the NMD pathway can remove aberrantly spliced transcripts once pro-
duced, a number of other regulatory mechanisms control mRNA expression before
this point by influencing spliceosome assembly. Efficient assembly depends on ac-
curate splice site recognition, and pre-mRNAs encode additional information that
aids or inhibits this process. In fact, one of the first studies into the regulation
of alternatively spliced transcripts from adenovirus revealed that secondary struc-
ture of the pre-mRNA heavily influenced splice site choice (Solnick 1985). It is not
feasible, however, for every transcript to contain sequences amenable to forming
strong hairpins. Rather pre-mRNAs contain short sequences, much like splice sites,
called splicing regulatory elements (SREs) that can be split into four categories:
exonic/intronic splicing enhancers (ESEs and ISEs) or exonic/intronic splicing si-
lencers (ESSs and ISSs). Depending on the intended functionality, these elements
either stimulate or repress spliceosome assembly at nearby splice sites through
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interactions with accessory regulatory proteins (Will & Luhrmann 2011).
Among the most well studied of these auxiliary spliceosome factors are two families
of ubiquitously expressed RNA binding proteins, SR proteins and heterogeneous
nuclear ribonucleoproteins (hnRNPs). SR proteins bind to enhancer elements and
then recruit members of U1 and U2 snRNPs through direct protein-protein inter-
actions (Busch & Hertel 2012). Contrarily, hnRNPs downregulate spliceosome
assembly, though the exact mechanistic details behind this regulation remain un-
clear (reviewed in Busch & Hertel 2012). Binding motifs for both proteins appear
near both constitutively and alternatively utilized splice sites, and the location
and frequency of these sites impacts both proteins’ effectiveness. However, this
effect seems to be more nuanced than what is currently understood. Although
exon inclusion rates correlate well with the distance between ESEs and splice
sites, adding more of these elements failed to further promote spliceosome assem-
bly (reviewed in Busch & Hertel 2012). Even so, increased binding potential does
not necessarily translate into increasing the amount of bound SR proteins. In
fact, the cellular concentration of many regulatory proteins is tightly controlled
through autoregulated feedback loops, typically by producing inactive isoforms
(Kelemen et al. 2013).
In addition to these proteins, more recent work discovered an abundance of trans-
acting RNAs can also influence splice site selection. Similar to SREs, micro RNAs
(miRNAs) do not directly interact with the spliceosome, but rather act on acces-
sory regulatory proteins. In one such example, miR-124 regulates the abundance
of PTB, a well known hnRNP, thus leading to increased exon inclusion rates due
to decreased levels of PTB (reviewed in Kelemen et al. 2013). Due to their own
unique expression profiles, other miRNAs target SR and hnRNP proteins to in-
directly regulate AS events in a tissue-specific manner. Furthermore, although
many are not spliced themselves, long non-coding RNAs (lncRNAs) have now
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been linked to AS regulation through control over the phosphorylation state of
SR proteins (reviewed in Kelemen et al. 2013). Additional roles for other non-
coding RNAs (e.g., tRNAs) have since been identified, though the breadth of this
method of regulation continues to be investigated.
1.2.1.4 Splicing Mutants and Disease
Considering the functional importance of many alternatively spliced isoforms, it
is not shocking that disrupting typical splicing patterns often leads to widespread
deleterious effects. Perturbation can be caused by mutations within splice sites,
introns, or the splicing machinery itself. An early instance of this was discovered
while investigating the aberrant expression profile of the β-globin polypeptide
associated with β-thalassaemia diseases (Treisman et al. 1983). Compared to
normal patients, those afflicted with the disease produced four extra isoforms that
either reduced or abolished polypeptide synthesis. Sequencing revealed that three
of these transcripts resulted from single nucleotide mutations surrounding the 5′
splice site. Though two merely weakened the splice site, the third mutation fell
within the 5′ dinucleotide and abolished splicing of the intron all together. The
final mutation, however, modified sequences within an upstream intron, generating
a novel 5′ splice site (Figure 1.10). This is sufficient to activate a nearby cryptic
3′ splice site and produce an isoform containing a disease-specific cassette exon.
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Figure 1.10: Schematic of the alternative spliced transcripts produced when the ß-thalassaemia gene
is mutated at position 745. This mutation creates a new 5’ splice site, shown in (B) compared to the
normal splice site and consensus sequences. This activates a nearby cryptic 3’ splice site at position
579, which is shown in (C). Figure from Treisman et al. 1983. Copyright 1983 Nature Publishing
Group.
Subsequent to this discovery, alternative splicing changes have since been con-
nected to countless diseases, including a wide range of cancers. Cancer-causing
mutations may occur in exons or introns, similar to B-thalassaemia, but can also
result from mutations in core and accessory spliceosome proteins (reviewed in
Climente-González et al. 2017). Many of these have been identified through
large-scale deep sequencing and bioinformatics analyses of cancerous tissues, and
have since been catalogued in The Cancer Genome Atlas (TCGA) (Weinstein et
al. 2013). By comparing more than 4,500 samples from 11 different cancer types
from TCGA, Climente-González et al. identified thousands of AS isoform switches
recurring amongst the tumors (Climente-González et al. 2017). The vast majority
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of these switches generated transcripts containing added or removed protein do-
mains and those with impaired or gained protein-protein interactions. However,
the authors could not pinpoint cis-acting somatic mutations responsible for these
switches, and suggested instead that many originated from trans-acting changes
within splicing factors. At this time, research continues to dissect the relationship
between these factors and observable phenotypic changes.
1.3 General mRNA Decay
Much like the aforementioned nuclear processing, clearance of mRNA from the cell
(i.e., general mRNA degradation or decay) is also accomplished through tightly
controlled processes involving numerous protein competents. Some of these pro-
teins, though not all, participate in two general mRNA decay pathways (Figure
1.11). Both require targeted mRNAs to first be deadenylated (Section 1.3.1), but
are then differentiated by whether degradation proceeds in the 5′-to-3′ (Section
1.3.2) or 3′-to-5′ (Section 1.3.3) direction. Although depicted as branched path-
ways, decay of some mRNAs happens in both directions (Garneau et al. 2007).
Collectively, the majority of mRNAs are removed by one or both of these path-
ways. A subset of the transcriptome, however, undergoes accelerated decay by
other means, and these quality control processes will be discussed further in Sec-
tion 1.4.
1.3.1 Deadenylation
General mRNA decay starts with progressive removal of the 3′ polyadenylated tail,
a process known as deadenylation (Figure 1.11, top). As is the case with much of
what has been discovered about mRNA decay, initiation via deadenylation was
25
Figure 1.11: Deadenylation-dependent decay pathways. Once the major deadenylase complex, Ccr4-
Not, shortens the poly(A) tail, mRNAs may be degraded from either side. Left, digestion at the 5’ end
begins when the cap is removed by Dcp2/Dcp2, exposing the mRNA to Xrn1. Right, the exosome
degrades mRNAs 3’-to-5’ and DcpS metabolizes the remaining cap structure. Figure adapted from
Garneau et al. 2007. Copyright 2007 Nature Publishing Group.
initially explored using reporter mRNAs in yeast (Decker & Parker 1993). By
measuring the length and abundance of various transcripts following transcription
inhibition, the authors calculated the relative rates of deadenylation and decay,
respectively. Although degradation of most analyzed mRNAs held off until dead-
enylation began, this was not the case for all transcripts. (Additional discussion
on deadenylation-independent decay pathways can be found in Section 1.3.4.) No-
tably, subsequent steps in mRNA turnover did not appear to require the complete
and absolute removal of the poly(A) tail. Captured decay intermediates main-
tained short tails that were typically long enough to accommodate a single copy
of poly(A)-binding protein (PABP) (Sachs et al. 1987).
Prior to deadenylation, PABP binds along the full length tail, potentially limiting
its exposure to cytoplasmic exonucleases during translation. Some such exonu-
cleases form the major deadenylation complex, hereafter referred to as Ccr4-Not
(Wiederhold & Passmore 2010). Though evolutionarily conserved, the role of
the Ccr4-Not complex in decay has been largely examined using knock-out yeast
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strains. When mutations impaired either exonucleolytic subunits (i.e., Ccr4 and
Pop2), reporter mRNAs deadenylated less efficiently (Tucker et al. 2002). This
effect could be rescued by overexpressing Ccr4p in either strain, suggesting this
protein serves as the primary exonuclease within the complex. In in vitro experi-
ments, Ccr4p activity was further tested in the presence and absence of purified
Pab1p, which slowed deadenylation rates in a concentration-dependent manner.
Even so, this inhibition was only observable when Pab1p significantly exceeded
the amount of Ccr4-Not complex. Whereas at equilibrium, Pab1p-bound mRNAs
deadenylated faster than naked transcripts, which suggests that PABP actually
stimulates Ccr4 (Webster et al. 2018). This stimulation appears to be particularly
vital in the turnover of short-tailed (≤ 15 As) transcripts, and could exist as a
final moment to control mRNA stability.
In fact, not all acts of deadenylation lead to decay. The poly(A) tail plays a crit-
ical role in regulating gene expression, much of which is mediated by PABP. For
example, direct interactions between PABP and initiation factors bound to the
5′ cap promote translation initiation (Tarun & Sachs 1996). When the Ccr4-Not
complex breaks these contacts by removing PABP during deadenylation, transla-
tion efficiency decreases in parallel. To understand the extent of PABP’s role in
gene regulation, short- (≤ 22 As) and long-tailed mRNAs in yeast were charac-
terized transcriptome-wide (Beilharz & Preiss 2007). Shorter tailed mRNAs were
bound by less copies of PABP, as expected, and less ribosomes, confirming transla-
tion repression occurs as a byproduct of deadenylation. In higher eukaryotes, the
relationship between tail length and ribosomal occupancy is used to regulate gene
expression in the absence of transcription (Novoa et al. 2010). This occurs in both
meiosis and early embryogenesis, during which cycles of tail shortening followed by
cytoplasmic polyadenylation control translation. Readenylation makes this initial
step of decay unique, and any further action commits an mRNA to destruction.
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1.3.2 5′-to-3′ Decay
One such irreversible path is known as 5′-to-3′ mRNA decay (Figure 1.11, left).
Following deadenylation, this pathway begins with the removal of the 5′ cap struc-
ture. When present, the cap is bound by eIF4E, a component of the translation
initiation complex (reviewed in Kapp & Lorsch 2004). This complex interacts
with PABP prior to deadenylation to load pre-translational ribosomal subunits
(Section 1.3.1). As one would expect, loss of the cap-binding activity of eIF4E
abolished these interactions and negatively impacted translation rates (Schwartz
& Parker 1999). mRNAs in this mutant background also degraded faster, more
so than the other translation factor mutations tested. Further analysis revealed
that cap-bound eIF4E inhibits the onset of decay by blocking decapping enzymes
during translation (Schwartz & Parker 2000). When eIF4E is removed, the cap be-
comes accessible and is rapidly cleaved by decapping proteins, Dcp1p and Dcp2p
(reviewed in Coller & Parker 2004). This cleavage event generates two products,
m7GDP and 5′-monophophaste mRNA, the latter of which is a preferred substrate
of the 5′-to-3′ exoribonuclease, Xrn1p.
In addition to the decapping enzymes and Xrn1p, there are a number of accessory
proteins involved in 5′-to-3′ decay. One such example is the decapping activator
complex, consisting of Pat1p and a heptameric ring of Lsm1p through Lsm7p, that
preferentially binds near the 3′ end of deadenylated mRNAs (Tharun & Parker
2001). In the absence of this complex (i.e., knock-out yeast strains), short-tailed,
capped mRNAs accumulated due to a reduction in decapping activity. Dcp2 is
now known to be recruited to mRNAs by direct interactions with Pat1p, but
mechanistic details beyond this continue to be investigated (Lobel et al. 2019).
Recent deep sequencing experiments, however, determined that the decapping
activator complex targets only a subset of the yeast transcriptome (He et al. 2018).
Some of these mRNAs are co-regulated by Dhh1p, another decapping activator,
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but still others responded only to one decay factor or the other (Dhh1p and its
role in regulating decay will be discussed later in Section 1.3.5). Furthermore,
knocking out any of the decapping activators did little to stabilize other transcripts
that undergo accelerated turnover through quality control pathways (Section 1.4).
Therefore, decay factors can trigger the onset of 5′-to-3′ degradation in varied
ways, providing different means of fine tuning gene expression.
1.3.3 3′-to-5′ Decay - The Exosome
An alternative pathway of mRNA decay can also occur at the 3′ end of the mRNA
(Figure 1.11, right). Like its 5′-to-3′ counterpart, decay via this pathway requires
a decapping enzyme, an exoribonuclease, and a number of associated protein fac-
tors (reviewed in Coller & Parker 2004). The exosome, the functional equivalent to
Xrn1p, is a large complex of exonucleases that digests both nuclear and cytoplas-
mic mRNAs. Exosome-mediated degradation produces a residual 5′ cap that is
then digested by DcpSp. Called “the scavenging decapping enzyme,” DcpSp pref-
erentially hydrolyzes shorter (≤ 15nt) RNA substrates, which precludes it from
5′-to-3′ decay (Liu et al. 2002). As this pathway concludes with cap processing,
decay factors must interact with the exosome to trigger degradation. Multiple
Ski proteins act in lieu of decapping activators, and the loss of even one inhibited
turnover of most analyzed transcripts (Anderson & Parker 1998). However, many
are dispensable for other exosome-mediated events (e.g., nuclear pre-rRNA pro-
cessing). This suggests that these proteins primarily function in identifying decay
substrates and recruiting the exosome for processing. In fact, they have since been
shown to be particularly vital to the rapid turnover of aberrant mRNAs lacking a
terminating codon (Section 1.4.3).
Though more clearly discussed as distinct RNA processing events, these two decay
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pathways often function simultaneously inside the cell. To tease apart the over-
lap between them, either direction of decay can be inhibited experimentally. For
example, 5′-to-3′ degradation can be blocked by deleting XRN1, inserting RNA se-
quences that block exonuclease progression, or adding translation inhibitors (Sec-
tion 1.3.5). Analysis of reporter mRNAs showed that the exosome is able to
compensate for the loss of 5′-to-3′ decay in any of these conditions (Muhlrad et
al. 1995). In wild type cells, however, only products of 5′-digestion were readily
visible. Though these results allude to exosome-mediated degradation as simply
a secondary pathway, this is not always the case. Decay in the nucleus predomi-
nantly occurs via the exosome. This was first shown to be true for pre-mRNAs in
yeast, which are stabilized in exosome mutant strains and less so by the absence
of the nuclear Xrn1p homologue, Rat1p (Bousquet-Antonelli et al. 2000). Later
studies confirmed this is the case for many nuclear non-coding RNAs (reviewed in
Moore 2002). Therefore, while pathways are favored differently in the cytoplasm
and nucleus, they functionally overlap in both compartments, thereby allowing
cells to remain viable when one is impaired.
1.3.4 Deadenylation-Independent Decay Pathways
Though the pathways described above are responsible for degrading the majority of
the yeast and human transcriptomes, other pathways can dispose of mRNAs prior
to deadenylation. The requirement to remove the poly(A) tail is bypassed when
substrates are made vulnerable in some way to the decay machinery. As deadeny-
lation otherwise limits the rate of Xrn1p and exosomal activity (Muhlrad et al.
1994), deadenylation-independent pathways provide a means for rapidly changing
gene expression. An example of this happens in yeast during the auto-regulation
of RPS28B (reviewed in Garneau et al. 2007). At higher concentrations, Rps28B
protein binds its own 3′ UTR and recruits Edc3p, a decapping activator, to trigger
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decay of the transcript (Figure 1.12, top). Moreover, poly(A)-tailed mRNAs can
be rendered susceptible to accelerated decay by several cellular endonucleases. En-
donucleolytic cleavage events create substrates for both Xrn1p and the exosome
at once (Figure 1.12, bottom). This is often used to limit translation of specific
mRNAs during cellular stress responses (reviewed in Garneau et al. 2007). In
other instances, endonucleases act on mRNAs when translation is stalled, which
accelerates their turnover through the No-Go Decay response (Section 1.4.4).
Auto-regulation of Rps28B
Endonuclease-mediated mRNA decay
Figure 1.12: Examples of deadenylation-independent mRNA decay. Top, RPS28B recruits Edc3p, a
decapping activator, to its 3’ UTR while still adenylated. Bottom, endonucleolytic cleavage events
lead to bi-directional mRNA decay. Figure adapted from Garneau et al. 2007. Copyright 2007 Nature
Publishing Group.
1.3.5 Transitioning From Translation to Decay
Before either the mechanisms or components of mRNA degradation were known,
the connection between translation and decay had already been well established.
This relationship was first studied by treating E. coli with different translation
inhibitors (Cremer et al. 1974). mRNAs in the presence of chloramphenicol, an
antibiotic that blocks ribosome translocation, were more stable than in wild type
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conditions. However, the addition of puromycin, which promotes ribosomal re-
lease, caused mRNAs to be more rapidly degraded. Similar changes in mRNA
turnover also developed when kasugamycin treatment blocked translation initia-
tion (Schneider et al. 1978). As a whole, these results illustrated that though
the ribosome does not function directly in the process of decay, both ribosomal
occupancy and active translation prevent mRNA degradation.
Once the decay machinery was identified, the focus shifted to understanding how
mRNAs transition from a state of active translation into decay substrates. Within
yeast, many of the factors involved in 5′-to-3′ digestion (e.g., Dcp2p, Dhh1p)
colocalize with decay intermediates in discrete cytoplasmic mRNPs, called “P
bodies” (Sheth & Parker 2003). Deleting any of these proteins individually caused
an increase in mRNA stabilization as the foci grew in both number and size.
However, P bodies disappeared within minutes of cycloheximide treatment, which
locks translocating ribosomes in place, illustrating that only ribosome-free mRNAs
enter into the mRNPs. Further studies confirmed this when reduced translation
initiation, either from a strong 5′ stem loop or inhibitors, led to enhanced P body
formation (reviewed in Franks & Lykke-Andersen 2008). Though translational
repression is a prerequisite for mRNP assembly, this is not a permanent fate.
Many mRNAs have since been found to exit P bodies and re-enter an active
translational state, particularly in response to cellular stress (reviewed in Franks
& Lykke-Andersen 2008). As such, mRNAs within P bodies appear to exist at a
transitional point between translation and degradation (Figure 1.13).
In order for P bodies to be the primary location for mRNA turnover, it would be
essential for decay intermediates to first exist in a ribosome-free state. To assess
this possibility, authors enriched for these mRNAs and their associated proteins in
∆dcp2 and ∆xrn1 mutant strains. The collected cellular material was separated
by sucrose density gradients into lighter (i.e., ribosome-free mRNPs) and heavier
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Figure 1.13: An early model for an mRNA’s progression from active translation to P body formation
and subsequent 5’-to-3’ decay. Though some specifics have since been proven incorrect, this figure
illustrates the proposed role of P bodies in mRNA degradation. Figure adapted from Coller and
Parker 2004. Copyright 2004 Annual Reviews.
(i.e., multiple ribosomes or “polysomes”) fractions (Hu et al. 2009). Surprisingly,
decay intermediates sedimented with the heavier polysome fraction. Similar sed-
imentation profiles were later observed for mRNAs harboring early termination
codons (Hu et al. 2010), which are known targets of accelerated decay (Section
1.4.1). These results conflicted with the requirement for P body formation prior
to degradation, and instead established that the majority of mRNAs undergo de-
cay co-translationally. And yet, precisely how these two processes were connected
remained unclear.
33
Prior to this finding, studies that explored the relationship between translation
and decay predominantly concentrated on initiation. However, even the earli-
est observations on mRNA stability noted that the wide variability in transcript
half-lives was only partially attributable to reduced initiation rates (reviewed in
Brawerman 1987). Given that transcripts are digested co-translationally, it follows
then that changes in elongation and/or termination could also trigger decay. To
observe the consequences of modifying elongation rates, rare codons were inserted
into the ORF of a reporter mRNA (Sweet et al. 2012). These codons code for
infrequently expressed tRNA molecules, and cause stalls in ribosome translocation
until the correct tRNA is inserted. Adding even ten rare codons led to a signifi-
cantly reduced mRNA half-life, but removing Dhh1p (i.e., ∆dhh1 strain) rescued
the effect. It was determined thereafter that codon optimality influences mRNA
half-lives transcriptome-wide (Presnyak et al. 2015), and that mRNAs coding for
sub-optimal codons are preferentially associated with Dhh1p (Radhakrishnan et
al. 2016). Together, these results implicate Dhh1p in monitoring elongation rates
in order to initiate decay on translationally inefficient mRNAs. As of now, addi-
tional details on the link between translation and normal mRNA decay continue
to be investigated.
1.4 Quality Control Pathways
In addition to the general mRNA decay pathway discussed above (Section 1.3), sev-
eral other surveillance mechanisms exist that target specific subsets of the mRNA
population for accelerated decay upon translation. These pathways (Figure 1.14),
which include nonsense-mediated decay (NMD, Section 1.4.1), non-stop decay,
(NSD, Section 1.4.3) and no-go decay (NGD, Section 1.4.4), are collectively known
as translation-dependent mRNA decay (TDD). Each is characterized by pathway-
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specific mRNA modifications that alter the typical translation rate (Figure 1.14).
These pathways were initially identified as a means by which cells could eliminate
problematic mRNAs before they can adversely impact the cell at the protein level.
If left unchecked, aberrant mRNAs can cause widespread phenotypic consequences,
including disease and cancer (Section 1.2.1.4). More recent work, however, has
elucidated the key roles that these mRNA turnover processes also play in post-
transcriptional gene regulation. In the sections below is a review of the history of
mRNA quality control and how these pathways mediate gene regulation.
1.4.1 Nonsense-Mediated Decay (NMD)
Premature stop codons, introduced either by genomic mutation (nonsense muta-
tion or frameshift) or altered pre-mRNA splicing, can result in the production
of dominant negative truncated proteins. In eukaryotic cells, however, most non-
sense and frameshift mutations are recessive, loss-of-function alleles. This is due
to elimination of the aberrant mRNA by a translation-dependent mRNA decay
pathway known as nonsense-mediated decay (NMD).
Rapid decay of mRNAs containing nonsense mutations, which introduce a chain-
terminating codon, was first studied in yeast (Losson & Lacroute 1979). Pulse
labeling experiments revealed that the wild type mRNA and an isoform with a
premature termination codon (PTC) were synthesized at the same rate. The decay
rate of the PTC-containing transcript, however, was greatly increased. Moreover,
this change in stability showed a position-dependent effect, as isoforms with PTCs
near the 5′ end of the open reading f rame (ORF) were turned over faster than
those with PTCs by the 3′ end. So fast, in fact, that an isoform with an early
PTC was undetectable at steady state.
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Figure 1.14: Mechanisms of mammalian translation-dependent mRNA decay (TDD): (a) Nonsense-
mediated decay (NMD), Section 1.4.1; (b) Non-stop decay (NSD), Section 1.4.2; (c) No-go decay
(NGD), Section 1.4.3. Figure from Garneau et al. 2007. Copyright 2007 Nature Publishing Group.
NMD transcripts are identified by a number of conserved protein factors, many
of which were initially determined through genetic screening experiments in C.
elegans and S. cerevisiae (Hodgkin et al. 1989; Pulak & Anderson 1993; Leeds
et al. 1991, 1992). The NMD machinery is inessential in both yeast and nema-
todes, providing ideal models to map out the pathway and proteins responsible.
In nematodes, however, loss of activity does lead to adverse cellular effects. Conse-
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quently, NMD factors were first discovered in C. elegans because loss of function
mutants led to physical abnormalities while stabilizing known PTC-containing
mRNAs (Hodgkin et al. 1989). As such, the six genes involved were named smg-1
through smg-6 for suppressor with morphological effect on genitalia. As for yeast,
the core proteins involved in the NMD pathway are Upf1, Upf2, and Upf3 – named
after the Up-f rameshift mutant isoforms that were stabilized upon their deletion
(Leeds et al. 1991). Homologous proteins were later identified in higher order
species (reviewed in Hug et al. 2015).
In yeast, Upf1, an RNA-dependent ATPase, associates with release factors, eRF1
and eRF3, and Upf2 on nonsense-containing isoforms in the cytoplasm (Figure
1.14a) (Mühlemann et al. 2008). Translation termination leads to interaction
with Upf3 and the phosphorylation of Upf1 by Smg1, causing dissociation of both
release factors and the ribosome. Additional Smg proteins subsequently recruit
general mRNA decay factors responsible for decapping and 5′-to-3′ exonucleolytic
digestion (Hug et al. 2015). Recent studies in yeast have shown that these isoforms
remain associated with polyribosomes even after decapping occurs, indicative of
the strong relationship between translation and NMD (Hu et al. 2010).
Along with the identification of the responsible protein factors, early genetic ex-
periments in C. elegans revealed that PTC-containing transcripts are not the sole
target of the NMD pathway (Pulak & Anderson 1993). Loss of smg proteins
stabilized the unc-54(r293) mutant mRNA, which is nearly 2kb longer than its
wild-type counterpart. This extension is the result of a deletion in the unc-54
3′ untranslated region (UTR) that removes the wild-type polyadenylation site.
This phenomenon was later studied in yeast (Muhlrad & Parker 1999), where the
destabilization of extended mRNAs was linked to the length of the 3′ UTR rather
than the presence of a specific sequence. Studies of mammalian 3′ UTR variants
have determined this regulation is conserved (Bühler et al. 2006). Through var-
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ious tethering experiments, it was shown that this particular NMD response is
controlled by interactions between poly(A)-binding protein (PABP) and eRF3, a
release factor, at the termination codon (reviewed in Mühlemann 2008). If the 3′
UTR is extended, PABP is deposited too far to compete with Upf1 to bind eRF3
during termination, leading to rapid degradation of the transcript by the NMD
machinery.
Though designation as an NMD-regulated transcript typically happens during
mRNA processing (i.e., mutations giving rise to PTCs, errors in splicing extending
UTRs), nonetheless an mRNA’s fate can be changed during translation itself.
While stalled at a pseudoknot or other pause-inducing secondary structure, the
ribosome may translocate at a “slippery site” of nucleotides to a different frame
through a single tRNA slippage (reviewed in Dinman 2012). Much like alternative
splicing (Section 1.2.1), −1 Programmed Ribosomal Frameshifting (-1 PRF) is a
means of expanding the transcriptome given a limited genome size. Though first
identified in multiple viral genomes, computational analyses showed that at least
one strong -1 PRF signal exists in nearly 10% of all yeast genes (Jacobs et al.
2007). Moreover, the use of ≥ 95% of these signals would result in termination
at a previously out-of-frame PTC, providing an opportunity for rapid decay of
mRNAs prone to erroneous translocation. Conservation of these rates was seen
across more than 20 eukaryotic transcriptomes (Belew et al. 2008).
As genome-wide experiments become more ubiquitous, it has become increasingly
obvious that the NMD-regulated transcriptome is not strictly limited to mRNAs
as initially believed. Loss-of-function mutants upf1-1 and upf3-1 in Arabidopsis
stabilized a class of mRNA-like non-coding RNAs in a genome-wide tiling array
(Kurihara et al. 2009). Similar results were obtained through deep sequencing
experiments performed in both mouse embryonic stem cells and yeast (Hurt et al.
2013; Smith et al. 2014). mRNAs containing upstream-ORFs (uORFs) and long
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non-coding RNAs (lncRNAs) increased in abundance when NMD was impaired in
these systems. NMD regulation of lncRNAs suggests that these transcripts are
present in the cytoplasm where they undergo some level of translation; this was
confirmed by ribosome profiling and polyribosome analysis (Smith et al. 2014).
It is now believed that mRNAs with uORFs or lncRNAs containing short ORFs
mimic transcripts with extended 3′ UTRs and may be regulated by NMD in a
similar fashion (Hurt et al. 2013; Smith et al. 2014).
1.4.1.1 Role of the Exon Junction Complex in NMD
Although the NMD machinery is conserved in all eukaryotes, the pathway in
higher order species involves a major protein complex not present in S. cerevisiae:
the EJC (Section 1.1.3). While expendable for NMD in C. elegans and Drosophila
(Mühlemann et al. 2008), the EJC is an essential part of mammalian NMD. Deple-
tion of eIF4AIII, one of the core EJC proteins described above, stabilized known
NMD targets in HeLa cells (Shibuya et al. 2004); MLN51 depletion showed a simi-
lar effect (Palacios et al. 2004). Moreover, loss of the conserved C terminal end of
Upf3, where Y14 binds, causes a loss of NMD in tethering experiments (Gehring
et al. 2003), indicating this bridge between the NMD machinery and the EJC
is required. The mammalian EJC proteome was analyzed via mass spectroscopy
and Western blots, confirming association with numerous regulatory and splicing
factors (including Upf3) (Singh et al. 2012).
One of the major contributions of the EJC to NMD is in the identification of
“premature” termination codons. EJCs within the coding region are necessarily
removed by the ribosome during the first, or “pioneer,” round of translation (Sec-
tion 1.1.3.2). As the ribosome translocates along the mRNA, it collides with the
EJC and other RNA-binding proteins, thus only proteins bound downstream of the
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first in-frame termination codon remain (Dostie & Dreyfuss 2002). Any remain-
ing EJCs bound more than 50 to 55 nucleotides downstream of the termination
codon serve as strong enhancers for NMD (reviewed in Maquat 2004). This signif-
icantly expands the NMD-regulated transcriptome in higher-order species beyond
mRNAs simply containing a nonsense mutation, long UTR, or a strong -1 PRF
signal. In the absence of all of these aforementioned triggers of NMD, splicing
events that leave bound EJCs in the 3′ UTR can shuttle mRNAs into rapid decay
by the NMD machinery.
1.4.2 NMD as a General Post-Transcriptional Regula-
tory Pathway
Thus far, NMD has been narrowly discussed as simply a means of clearing the
cell of aberrantly translated RNAs, but it is also a key post-transcriptional gene
expression regulation pathway. The simplest example of this occurs when -1 PRF
is coupled to NMD. The wild-type and NMD-regulated transcript are one and the
same, until a substantial pause in translation causes abrupt decay. Gene expression
of certain cytokine receptors in mammalian cells is believed to be regulated in this
way (Belew et al. 2014). When a microRNA binds to the cytokine receptor mRNA,
a stable pseudoknot is formed downstream of a slippery stretch of nucleotides,
consequently introducing a PTC through -1 PRF. A rise in the transcription of the
microRNA increases clearance of the mRNA through this NMD-causing binding
event, thereby regulating the immune response to viral cytokines.
Nevertheless, NMD-regulated gene expression most often results from alternative
splicing events that introduce PTCs during nuclear mRNA processing. As in the
initial discovery of the NMD machinery, C. elegans provided the ideal system
to explore questions about how post-transcriptional gene expression is regulated
40
through alternative splicing coupled to NMD (AS-NMD). Products of the smg
genes were first linked to alternative pre-mRNA processing of two SR protein mR-
NAs (Morrison et al. 1997). Genes encoding these mRNAs also each code for an
alternatively spliced isoform with an in-frame stop codon; these AS-NMD tran-
scripts are stabilized in smg(-) mutants. Similar results were observed in later
studies of the alternative splicing of ribosomal proteins (Mitrovich & Anderson
2000). In both cases, when smg genes were mutated, AS-NMD transcript abun-
dance was more than or equal to that of the wild type isoform, indicative of a high
level of unproductively spliced mRNAs in wild type cells.
Conservation of gene regulation via AS-NMD was evident even in early construc-
tions of the human transcriptome (Lewis et al. 2003). Based on alignments of EST
sequences to a RefSeq annotation, AS-NMD was initially estimated to regulate
one-third of the approximately 16,000 mRNAs. Homologs of the aforementioned
C. elegans SR and ribosomal proteins were among this pool, suggesting conserved
regulation of their expression. In fact, subsequent EST studies showed that all
human SR protein genes contain ultraconserved regions that act as poison cassette
exons when included (Lareau et al. 2007). Exon inclusion has since been found
to act as a conserved method of autoregulating the homeostatic gene expression
of many trans-acting splicing factors, including SR proteins (Ni et al. 2007).
The true extent of post-transcriptional regulation via AS-NMD was not known
until transcriptomes were assembled from deep sequencing datasets. Analysis
based on EST sequences is inherently biased towards stable mRNAs, precluding
many short-lived regulatory transcripts (Lewis et al. 2003). RNA-Sequencing
(RNA-Seq) experiments introduce their own issues (discussed further in Section
1.6), but the sheer depth of information allows for improved recovery of AS-NMD-
regulated transcripts. Genome-wide analysis after knocking down polypyrimidine
tract-binding protein 1 (Ptbp1), a splicing repressor, revealed its role in regulating
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expression by controlling 5′ and 3′ splice site (SSs) choice on many pre-mRNAs
(Hamid & Makeyev 2014). Among these genes, AS-NMD controls the regulation
of proteins involved in organelle biogenesis (Hamid & Makeyev 2014), neural de-
velopment (Zheng et al. 2012), and chromatin modification (Yan et al. 2015).
Further transcriptome-wide experiments have since revealed numerous pathways
regulated by AS-NMD in Arabidopsis (Drechsel et al. 2013), C. elegans (Longman
et al. 2013), and S. cerevisiae (Kawashima et al. 2014).
1.4.3 Non-Stop Decay (NSD)
Post-transcriptional regulation is also achieved through Non-Stop Decay (NSD),
another TDD pathway conserved from yeast to humans (reviewed in Klauer &
Hoof 2012). NSD specifically degrades transcripts that fail to terminate transla-
tion. This typically arises from mutations in the normal stop codon, products
of aborted transcription events, and premature polyadenylation due to cryptic
poly(A) signals. Like NMD, NSD was first identified in S. cerevisiae (Frischmeyer
et al. 2002; Van Hoof et al. 2002). A reporter mRNA without a stop codon was
rapidly degraded in mutant strains lacking either the NMD machinery (upf1∆) or
the general 5′-to-3′ decay machinery (xrn1∆ or dcp1-2) (Frischmeyer et al. 2002).
Deleting components of the exosome (ski2∆, ski3∆, ski7∆, or ski8∆), however,
stabilized the NSD transcript (Van Hoof et al. 2002). The C terminal half of Ski7
is required for this stabilization. This region resembles two GTPases, EF1A and
eRF3, that interact with the A site of the ribosome during translation. When
ribosomes reach the end of the poly(A) tail rather than properly terminating, Ski7
is thought to bind to the empty A site and trigger decay by the exosome (Figure
1.14b). As Ski7 is not conserved, the mammalian exosome instead interacts with
Hbs1L and Pelota (the mammalian homologs of Hbs1 and Dom34, respectively)
to recognize and eliminate NSD transcripts (Saito et al. 2013).
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1.4.4 No-Go Decay (NGD)
The three phases of translation are initiation, elongation, and termination. Early
termination events trigger NMD, and failure to terminate prompts degradation by
NSD. The rate of elongation is monitored by the final major TDD pathway, No-
Go Decay (NGD). During translation, ribosomes may encounter strong secondary
structures (i.e., stem-loops and pseudoknots) or rare codons that stall further
translocation. Introducing any of these features into reporter mRNAs decreased
their steady-state abundance in yeast (Doma & Parker 2006). Full-length mRNAs
containing a stem-loop in the ORF were rescued by impairing either the 5′-to-3′
or the 3′-to-5′ decay pathways. The mutants also stabilized RNA fragments 3′
or 5′ of the stem-loop, respectively. Both fragments, however, were missing in
dom34∆ and hbs1∆ strains. In addition to their role in mammalian NSD (Section
1.4.2), Pelota/Dom34 and Hbs1L/Hbs1 bind stalled ribosomes and cause subunit
dissociation, thereby activating NGD (Shoemaker et al. 2010). Neither, however,
is the endonuclease responsible for creating the aforementioned RNA fragments
(Passos et al. 2009). Although this protein has yet to be identified, recent ex-
periments showed that endonucleolytic cleavage only occurs when ribosomes are
stacked within the ORF (Simms et al. 2017). Once cleaved, mRNA fragments are
degraded by both the exosome and general decay machinery (Figure 1.14c).
1.4.5 NSD/NGD as General Post-Transcriptional Reg-
ulatory Pathways
Unlike NMD, evidence of NSD and NGD regulating post-transcriptional gene
expression is limited. Due to the overlapping functions of Pelota/Dom34 and
Hbs1L/Hbs1, the identification of naturally occurring transcripts targeted by these
pathways has largely occurred in parallel. Transcriptome-wide studies in dom34∆
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and hbs1∆ yeast strains identified HAC1 mRNA as a regulated substrate (Guy-
dosh & Green 2014). HAC1 is exported to the cytoplasm while still containing
its first intron. The mRNA is spliced under cellular stress, allowing translation of
a stress-specific transcription factor (Harigaya & Parker 2012). Otherwise, under
normal conditions, endonucleolytic cleavage at the 5′ splice site leaves a truncated
HAC1 transcript. This short mRNA is up-regulated in the knockout strains. Ei-
ther improper termination at the 5′ end of the exon or the resulting ribosome
stalling upstream may trigger degradation via NSD or NGD, respectively (Guy-
dosh & Green 2014).
Though HAC1 is the only known mRNA to be regulated in this manner in S.
cerevisiae, many such substrates have been identified in S. pombe. In this yeast,
a stress response occurs when unfolded or misfolded proteins accumulate at the
endoplasmic reticulum (ER) (Guydosh et al. 2017). The unfolded protein response
activates signal transduction pathways that fold proteins while also limiting further
translation. Like HAC1, mRNAs at the ER are cleaved and rapidly degraded. Of
the nearly 500 mRNAs regulated in this manner, the vast majority (91%) contain
an ER-specific signal sequence or transmembrane domain. This indicates that
NSD and NGD play a significant role in homeostasis of this organelle. Further
studies of similar stress responses are needed to determine if this regulation is
conserved mammalian cells.
1.5 Transcriptome Annotation
A full understanding of how TDD contributes to the regulation of gene expres-
sion requires a transcriptome annotation that is both complete and accurate. Al-
though the human transcriptome is mentioned here and elsewhere as a specific
entity, there is striking variability between annotations. This reflects the diversity
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of gene expression, much of which is dictated by factors such as cell type and
environmental conditions. Further, transcriptome annotation is highly dependent
on the processes used to derive the annotation and in the decisions of what are
“true” or “functional” transcripts and what are not.
There are currently four major human transcriptome annotations or “references”:
RefSeq (Pruitt et al. 2005), Ensembl (Curwen et al. 2004), GENCODE (Harrow
et al. 2012), and CHESS (Pertea et al. 2018). Although there is substantial
overlap, each has its own idiosyncrasies, resulting in thousands of reference-specific
annotations. To illustrate the extent of overlap and differences between references,
the number of exon junctions with shared or unique annotations is depicted in
Figure 1.15. Notably, of the approximately 550,000 annotated junctions, only
45% are found in all four references reviewed below.
Figure 1.15: Comparison of annotated exon junctions among the transcriptomes sourced from Ref-
Seq (hg38), Ensembl (GRCh38.p12), GENCODE (v29), and CHESS (v2.1). Horizontal bars: total




The reference human transcriptome with the smallest number of exon junctions
(Figure 1.15) is RefSeq (for Ref erence Sequence), curated by the National Center
for Biotechnology Information (NCBI) at the US National Institutes of Health
(Pruitt et al. 2005). The RefSeq database contains a collection of the latest
genome, transcript, and protein annotations, which are frequently updated in
each “release.” As of release 93 (available in March 2019), RefSeq covered 88,816
organisms, including but not limited to: bacteria, fungi, viruses, vertebrates, and
plants (O’Leary et al. 2016). Hereafter, my focus will be on the human annotations
provided by RefSeq.
Transcriptome assembly by RefSeq involves a combination of automatic and man-
ual annotation processes (Pruitt et al. 2014). Much of the RefSeq human tran-
scriptome is based on publicly available RNA-Seq datasets processed through
the NCBI Eukaryotic Annotation Pipeline. Datasets are sourced from both the
International Nucleotide Sequence Database Consortium (INSDC) and, more re-
cently, the Short Read Archive (SRA), and chosen based on depth and lack of
tissue-specificity or treatment to ensure individual-to-individual consistency. An-
notation of the non-coding transcriptome (e.g., pseudogenes, micro-RNAs), how-
ever, has typically been performed by other sources, such as miRBase, and then
incorporated into RefSeq (Pruitt et al. 2014).
RefSeq is the most conservative in annotation among the discussed references, a
result of their unique goal to provide a non-redundant collection of full-length
transcript and protein sequences (O’Leary et al. 2016). Consequently, an mRNA
annotated in RefSeq is likely true, however many real transcripts are omitted.
Therefore the absence of a transcript from RefSeq should not be interpreted
as proof it does not exist. This is readily visible when comparing RefSeq to
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other databases (Table 1.1). One reason for the lower number of transcripts in
RefSeq is its systematic under-representation of alternative isoforms. Rather than
annotate multiple short isoforms, transcripts with mutual first and final exons
are extended to share the same 5’ and 3’ ends (Frankish et al. 2015) (Figure 1.16,
top transcripts). Thus RefSeq under-reports alternative transcription start and
polyadenylation sites (TSS and PAS, respectively). With regard to protein-coding
transcripts, RefSeq often labels many as “non-coding” (or “NR”) due to features
such as 3′ UTR exon junctions regardless of evidence indicating their productive
translation (reviewed in Bicknell et al. (2012)). Other examples of transcripts
that were previously left out or labeled as NR include those encoding proteins
containing selenocysteine (which is encoded by UGA within a particular sequence
context) and transcripts that engage in -1 ribosomal frameshifting. Recent efforts
by manual curators have begun to address some of these deficiencies (Rajput et
al. 2019), but this remediation work remains incomplete.
Table 1.1: Features of the human genome and transcriptome in each annotation source.
Feature RefSeq Ensembl GENCODE CHESS
Protein-coding Genes 20,070 20,418 19,940 21,306
Non-coding Genes 17,710 22,107 23,643 21,856
Transcripts 113,224 206,762 206,694 323,824
Exon Junctions 325,855 356,956 361,387 469,743
1.5.2 Ensembl and GENCODE
Though maintained by different sources, Ensembl and GENCODE [a genome re-
search project at ENCODE (ENCyclopedia Of DNA Elements)] are best described
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Figure 1.16: Comparison of GENCODE and RefSeq Annotation in the UCSC genome browser display-
ing the SLC25A17 locus. Novel GENCODE splicing features are highlighted in red (novel cassette
exons), blue (novel alternative splice site, or shifted splice site) and green (novel putative TSS and
5’ UTR). Figure from Frankish et al. 2015. Copyright 2015 BioMed Central.
together because of the high degree of overlap in their annotation process and
resulting transcriptomes. Similar to RefSeq, Ensembl provides annotations for a
large variety of organisms, however GENCODE focuses solely on humans and mice.
The European Bioinformatics Institute curates the Ensembl database through
an automatic pipeline, known as their Ensembl Annotation Process (Down et al.
2002). Once assembled, Ensembl annotations are merged with manual annotations
from the HAVANA (Human and Vertebrate Analysis and Annotation) group to
form the GENCODE reference (Harrow et al. 2012). The two transcriptomes end
up being nearly identical, with differences primarily located in duplicated regions
and pseudogenes.
Although data for the Ensembl Annotation Process pipeline is sourced from RNA-
Seq libraries in the INSDC (Aken et al. 2016), just as is RefSeq, the resulting
Ensembl and GENCODE transcriptomes are much larger than RefSeq (Table 1.1).
As previously mentioned (Section 1.6), some level of variation between the an-
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notations is expected. A major reason for this difference is how each database
represents alternative events. Rather than extending an isoform to the full-length
transcript, annotation requires support from biological evidence at each nucleotide
(Frankish et al. 2015). This results in many more short isoforms in the Ensembl-
and GENCODE-annotated transcriptomes, increasing the number of transcripts
per gene to 4.8 and 4.7, respectively, compared to 3.0 in RefSeq (from Table 1.1).
Included in these isoforms are a number of alternative processing and splicing
events (Figure 1.16). Although this may include some false positives from shorter
RNA-Seq reads, it allows these transcriptomes to more accurately depict the full
extent of alternative splicing in the human transcriptome.
1.5.3 CHESS
The Salzberg lab recently attempted to address the discrepancies between Ref-
Seq, GENCODE, and other databases by assembling more complete and accu-
rate human genome and transcript annotations, dubbed CHESS (Comprehensive
Human Expressed SequenceS, Pertea et al. (2018)). The annotation process,
again, hinges on RNA-Seq data, this time originating from a massive Genotype-
T issue Expression (GTEx) study (The GTEx Consortium et al. 2015) instead of
the INSDC. CHESS was built from 9,725 sequencing libraries with a total depth
just shy of 900 billion reads (Pertea et al. 2018). Predicted annotations were
strictly filtered by several criteria, including conservation and reproducibility, to
eliminate potential alignment artifacts and splicing noise. Though the genome in-
creased a marginal amount, the CHESS transcriptome nearly tripled compared to
RefSeq (Table 1.1). Still, more than 80,000 exon junctions annotated by other ref-
erences, predominantly Ensembl and GENCODE, did not appear in the CHESS
transcriptome (Figure 1.15). Many of these junctions are found in non-coding
transcripts, and were likely lost to computational filters designed to remove non-
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functional, low abundance transcripts (Pertea et al. 2018). This indicates, how-
ever, that even the most comprehensive analysis of RNA-Seq data cannot capture
all known splicing events.
1.5.4 Other Transcriptome Annotations
In addition to RefSeq, Ensembl, GENCODE, and CHESS, there are other human
transcriptome annotations available. Other studies have compared these references
to the four described in detail here. The UCSC Known Genes annotation, the
basis for the UCSC Genome Browser, performs similarly to RefSeq in mapping
analysis (Zhao & Zhang 2015). The Moore lab has historically used RefSeq for
bioinformatic analyses so it was chosen between the two. A broader study of
annotations included transcriptomes from the H-InvDB Genes, AceView Genes
and VegaGenes databases (Wu et al. 2013). VegaGenes is now merged with
Ensembl/GENCODE. The others are no longer updated.
1.5.5 Impact of Annotation Choice on Data Analysis
With the advent of deep sequencing in the 2000’s, RNA-Seq rapidly emerged as
the method of choice for assessing differential gene expression. The outcome of
any differential gene expression experiment is highly dependent, however, on what
reference is used to align the RNA-Seq reads. For short RNA-Seq reads (≤ 50
nt), alignment to the genome of interest can be sufficient. On the other hand,
reads that span exon junctions will have low mapping scores and so will likely be
excluded from the analysis. With reads of 75 nts, for example, Zhao reported a
33 - 37 percent difference in the fraction of reads mapping when using only the
human genome as a reference versus the genome plus the RefSeq transcriptome
(Zhao 2014). Almost all of the reads that failed to map in the genome-only align-
50
ment spanned one or more exon junctions. As new RNA-Seq technologies allow
for increasingly longer sequenced reads, this discrepancy becomes even larger and
the likelihood that a read crosses one or more exon junctions rises dramatically
with read length. That is not to say that merely having a reference transcrip-
tome is sufficient. Incomplete or inaccurate annotations are known to affect the
quantification of alternatively spliced isoforms (Pyrkosz et al. 2013). Fortunately,
the sources detailed above (Sections 1.5.1-.3) continue to be updated with the
most recent annotations (“releases”), so the question when studying the human
transcriptome has become a matter of which database to use.
Unfortunately, the question of which database to use is rarely answered on an
experiment-specific basis, though recent work has shown that it ought to be (Wu
et al. 2013). In that study, both RefSeq and Ensembl annotations (and others
mentioned in Section 1.5.4) were ranked by their complexity, a calculation based
on the number of genes, transcripts, and exons. Ensembl ranked at higher com-
plexity than RefSeq in every category. The latest numbers, including counts of
exon junctions, agree with this finding (Figure 1.15 and Table 1.1). Based on
the effect complexity had on both mapping and differential gene expression, the
authors concluded that less complex annotations (i.e., RefSeq) are sufficient when
studying differential expression at the gene-level (Wu et al. 2013). Accurate esti-
mates at the transcript-level, particularly for non-coding and/or regulatory RNAs,
however, required more complex transcriptomes like Ensembl. A later comparison
between RefSeq and GENCODE led to similar conclusions (Frankish et al. 2015).
Therefore, reference annotations need to be selected based on overall experimental
design rather than simply a matter of convenience.
Nevertheless, recall that the majority of exon junctions are absent from at least
one reference (Figure 1.15), meaning that no one current annotation is complete.
Merging multiple transcriptomes, a crude attempt at a more “complete” anno-
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tation, was shown to improve transcript quantification in comparison to either
parent reference (Chen et al. 2013). Still, filters based on abundance thresholds
during the annotation process have led to the absence of known regulatory RNAs
with cell- and/or condition-specific expression profiles, including many related to
disease (Morillon & Gautheret 2019). In fact, analysis of 21,500 RNA-Seq libraries
from SRA identified more than three million exon junctions (each with ≥ 20 reads
per junction) in the human transcriptome (Nellore et al. 2016). This is nearly a
ten-fold increase compared to RefSeq, which also uses data from SRA (Pruitt et
al. 2014). Additional data from single-molecule and short-read RNA-Seq experi-
ments targeting weakly expressed RNAs suggest that GENCODE could be missing
half of the alternative isoforms transcribed from non-coding gene loci (Deveson
et al. 2018). While these counts may be inflated by false positive exon junctions,
many unannotated regulatory RNAs unquestionably exist and should be taken
into account when considering the human transcriptome.
1.6 Identifying TDD Transcripts in Mammalian Systems
As discussed in Section 1.4, TDD of alternatively processed transcripts has been
well established as a key post-transcriptional regulatory process in higher eukary-
otes. When included in annotations, these transcripts are typically labelled by
their method of degradation (e.g., “nonsense-mediated decay”), which provides
one way to estimate the prevalence of TDD regulation. In the latest human tran-
scriptome from Ensembl, for example, nearly 15,000 transcripts are marked as
known NMD substrates (Cunningham et al. 2019). Yet this value cannot repre-
sent the full extent of TDD regulation as many transcripts have expression profiles
linked to specific conditions (e.g., development, cell differentiation, disease) and
are thus are often missing from transcriptome annotations altogether. Many stud-
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ies have therefore attempted to identify additional TDD targets by manipulating
conditions to slow their decay.
One of the first methods for identifying TDD substrates was depletion of selenium,
an essential trace element. When selenium is present, UGA codons upstream of a
~60 nt hairpin (known as a selenocysteine insertion sequence, or SECIS, element)
are decoded as selenocysteine codons and a full length selenoprotein is translated
(Figure 1.17) (Moriarty et al. 1998). When the cell is deficient in selenium, how-
ever, these codons are recognized as stop codons. When early in the coding region,
they are essentially PTCs that lead to NMD of the mRNA. Selenium depletion has
been exploited to determine/confirm key mechanistic details of NMD, including
but not limited to: (1) NMD occurs in the cytoplasm (Moriarty et al. 1998); (2)
NMD requires translation; (3) NMD depends on intron position near PTCs (Sun
et al. 2000); and (4) degradation can be cell type-specific (Sun et al. 2001). Al-
though the regulation of mRNAs encoding selenoproteins has been shown to play
a role in cellular processes such as immune function, muscle development, and fer-
tility, there only about 300 such mRNAs annotated in the human transcriptome
(Rajput et al. 2019).
Figure 1.17: Schematic of mRNA that can be translated as either a selenoprotein or a NMD-regulated
transcript depending on how the ribosome decodes the indicated UGA codon. Figure adapted from
Rajput et al. 2019. Copyright 2019 Oxford University Press.
As translation is required for decay, any inhibitor that blocks protein synthesis
will also stabilize TDD-regulated mRNAs. An early study demonstrated that ex-
pression of a NMD reporter substrate was up-regulated in the cytoplasm upon
addition of any of six different translation inhibitors, regardless of their inhibition
mechanism (Carter et al. 1995). These experiments helped to confirm the link
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between translation and NMD. Since then, a number of small molecule inhibitors
that directly affect translation and/or decay protein factors have been identified.
For instance, phosphorylation of Upf1, a required step to initiate NMD, can be
blocked by the addition of either NMDI-1 or caffeine in human cell lines (Keel-
ing et al. 2013). Both small molecules have been employed in a method dubbed
Gene Identification by NMD Inhibition (GINI) (Noensie & Dietz 2001). Potential
cancer-related NMD substrates were identified using GINI by comparing the tran-
scriptomes of normal and disease cell lines to find caffeine-induced stabilization
(Johnson et al. 2012). However, the high degree of discordance between findings
from different studies and a high number of false positives (reviewed in Johnson
et al. 2012) has hindered the wide-spread adoption of GINI as a general NMD
substrate identification method.
Eliminating one or more protein factors required for decay (Figure 1.14) is a power-
ful approach to identifying TDD targets. Investigations into NMD as a regulatory
pathway in mammalian systems were initially limited by the fact that the Upf
proteins are essential in these species. This eliminates the option of simply delet-
ing these genes and monitoring which transcripts are consequently stabilized, a
common approach used to study NMD in yeast and nematodes. In cell lines,
mRNAs encoding the NMD machinery can, however, be depleted by transfecting
targeted short interfering RNAs (siRNAs). Cells remain viable as siRNA-mediated
knockdown is efficient yet not absolute. Using microarrays, reduced expression of
Upf proteins was shown to affect (≥ 1.9-fold change) between 4 and 9% of tran-
scripts analyzed (Mendell et al. 2004; Wittmann et al. 2006). Common features
of NMD-regulated transcripts (e.g., long 3′ UTRs, uORFs) were made apparent
by comparisons of the microarray-based transcriptome profiles after transfecting
different siRNAs (Yepiskoposyan et al. 2011). Moreover, Gene Ontology (GO)
analysis showed genes involved in alternative splicing or the NMD pathway itself
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were consistently up-regulated across all NMD-knockdown transcriptomes.
All of the above transcriptome-wide studies relied on microarrays. While microar-
rays are adaptable and can be designed to target specific mRNAs, such as PTC-
containing splice variants (Pan et al. 2006), the reach of this method is limited to
known and abundant transcripts. The switch from microarrays to RNA-Seq in the
late 2000’s expanded not only the scope of detectable transcripts, but also the ques-
tions that can be answered. For example, reporter mRNAs with extended 3′ UTRs
are known to be regulated by NMD (discussed in Section 1.4.1). It was not known,
however, what causes these mRNAs to undergo NMD rather than the general de-
cay pathway. Data from CLIP-Seq, a targeted immunoprecipitation followed by
RNA-Seq, revealed UPF1 binding events are, in fact, biased transcriptome-wide
towards 3′ UTRs that are longer than average (Hurt et al. 2013). This same
bias is seen amongst up-regulated transcripts in Upf1 knockdown cells (Colombo
et al. 2017). Further bioinformatic analysis of these UTRs identified a GC-rich
motif thought to stall Upf1 translocation, increasing the likelihood of it becoming
phosphorylated by Smg1 and triggering NMD (Imamachi et al. 2017).
Although much important insight has been gained from the approaches discussed
above, they all fall short of a true representation of the initial or “pre-translational”
transcriptome (i.e., the complete set of transcripts generated in the nucleus prior
engagement by ribosomes). Under wild-type conditions, mRNA isoforms vary
greatly with regard to cytoplasmic degradation rate. As such, the currently avail-
able methods can only provide a static snapshot of the transcriptome while reveal-
ing little about the flux through mRNA processing pathways. While individual
decay pathways can be slowed by the methods discussed above, long-term inhibi-
tion can result in confounding pleiotropic effects. For example, simply inhibiting
NMD activates autophagy in mammalian cells, which in turn leads to a marked
increase in cell death in less than 48 hours (Wengrod et al. 2013). Yet siRNA
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treatments typically take much longer than this for adequate depletion (Mendell
et al. 2004; Wittmann et al. 2006). Furthermore, all of the commonly used
translation inhibitors are known to activate other signaling pathways (Sidhu &
Omiecinski 1998). Transcriptomes assembled from these experiments, therefore,
are influenced to an unknown degree by TDD-independent changes in gene expres-
sion.
1.7 The Pre-translational Transcriptome
TDD-regulated transcripts exist for a very limited timeframe in wild-type cells. To
better capture these transcripts, methods are needed to specifically select for the
population of mRNAs that have completed splicing but have not yet been trans-
lated. This eliminates the influence of varied translation-dependent decay rates.
Transcriptomes assembled from pre-translational mRNAs should thus provide a
more accurate record of the flux through various alternative processing pathways.
1.7.1 Isolation of Specific RNA Populations
Specific populations of RNAs have been previously purified using isolation meth-
ods that enrich for either RNA-RNA or RNA-protein interactions. Full length
mRNAs, for example, can be selected using oligo(dT) primers that hybridize to
long stretches of adenosines. As general decay initiates upon deadenylation and
other RNAs (i.e., ribosomal RNAs) are not adenylated, these probes will primarily
bind to the poly(A) tails of fully processed mRNAs not yet subject to deadenyla-
tion. Contaminating RNAs (i.e., non-mRNAs) are often depleted during RNA-Seq
library preparations with this method (Sultan et al. 2014; Lykke-Andersen et al.
2014; Saudemont et al. 2017). Although the oligonucleotide sequence can be
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changed to purify or deplete other RNA species, a significant number of probes
are necessary unless the targeted sequence is shared (e.g., RiboZero).
An alternate approach to enriching for RNA species with a particular property,
but whose sequences are unknown is to pull down an RNA binding protein (RBP)
along with its associated RNAs. In addition to sequence motifs, different RBPs
recognize secondary structures (e.g., hairpins) and other structural elements (e.g.,
5’ cap or poly(A) tail). Many of these proteins are involved in post-transcriptional
gene regulation, from pre-mRNA processing (Section 1.1) to decay (Section 1.4).
As such, knowing the mRNAs targeted by these proteins can help answer many
questions about how regulation is mediated. Bound mRNAs can be isolated and
identified using RNA immunoprecipitations (RIP) (Tenenbaum et al. 2000). The
combination of RIP with high-throughput sequencing (RIP-Seq) expands this anal-
ysis to a transcriptome-wide scale (Zhao et al. 2010; reviewed in Singh et al. 2014).
For information on precisely where RBPs bind RNA, RIP experiments may include
a nuclease treatment step, which destroys unbound and exposed RNA. Remaining
RNA fragments are known as “footprints.”
However, the interaction of many RBPs with RNA is dynamic. Consequently,
RBPs may dissociate during RIP. Though some remain unbound, many will re-
associate with other RNA fragments in the cell lysate and create new footprints
that were not present in intact cells (Mili & Steitz 2004). Crosslinking agents
(i.e., UV or formaldehyde) induce covalent bonds between RNAs and proteins
at their site of interaction. The links formed by UV crosslinking prior to RIP,
known as crosslinking and immunoprecipitation (CLIP), also allow for the use of
more stringent purification conditions (Ule et al. 2003). For example, harsher
washing of bound material removes indirect protein-RNA interactions, increasing
the signal-to-noise ratio. Since its creation in 2003, many other CLIP-based tech-
niques (e.g., CLIP-Seq, PAR-CLIP, iCLIP) have been developed, each modifying
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specific step(s) in the methodology (reviewed in Hannigan et al. 2018). CLIP-Seq,
the deep sequencing of CLIP RNA, helped identify the mechanism behind Upf1-
mediated decay of long 3′ UTRs (Section 1.6; Hurt et al. 2013; Imamachi et al.
2017).
CLIP methods provide exquisitely precise information as to the location of RNA-
protein interactions that are amenable to the crosslinking approach used. How-
ever, they can only reveal the crosslinking locations for individual proteins, and
not multi-protein complexes. While many RBPs do function as individuals [e.g.,
Nova (Ule et al. 2003); Staufen (Ricci et al. 2014)], many others function as part
of larger complexes (e.g., spliceosomes). These larger complexes contain both
proteins that directly contact the RNA and other more distal components whose
locations cannot be captured by CLIP. In addition, because the composition of
many macromolecular complexes that interact with RNA is highly dynamic (e.g.,
the spliceosome cycle), just knowing where a particular protein binds provides no
information as to which complex that protein is contained in. One method for puri-
fying these macromolecular complexes is to perform sequential RIPs using different
complex-specific proteins. This method, called RNA:protein immunoprecipitation
in tandem (RIPiT) (Singh et al. 2012, 2014), has been used to study RBPs and
their complexes in both yeast and human cell lines (Singh et al. 2012; Ricci et al.
2014; Chen et al. 2014, 2018; Yang et al. 2014; Mabin et al. 2018). The differ-
ences in purified material between a RIP-based approach and RIPiT are shown in
Figure 1.18.
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Figure 1.18: Differences in outputs from RIPiT and CLIP experiments. Blue: RNA-binding proteins;
green: non-RBPs; red/yellow: complex-specific proteins. RIPiT reveals complex-specific information,
whereas CLIP can only show sites of RNA-protein interactions. Figure from Singh et al. 2014.
Copyright 2014 Elsevier.
1.7.2 Accessing the Pre-Translational Transcriptome
through the EJC
The ideal target for accessing the pre-translational transcriptome is the exon junc-
tion complex (EJC). Late in the splicing cycle, EJCs are deposited on mRNAs
upstream of exon-exon junctions in a sequence-independent manner (Le Hir, Iza-
urralde, et al. 2000; Shibuya et al. 2004). The EJC remains stably bound
until a translating ribosome forces its removal in the cytoplasm (Section 1.1.3).
Thus, the EJC-associated transcriptome records nuclear processing events prior
to translation-dependent regulation.
The Moore lab has previously used RIPiT to preferentially purify pre-translational
mRNPs from mammalian cell lines (Figure 3.4; Singh et al. 2012; Metkar et al.
2018). To do so, inducible transgenes encoding individual EJC core proteins with
59
FLAG epitope tags were stably integrated (Flp-in) into HEK293 cells. Tetra-
cycline titration allows for FLAG-tagged protein expression at near endogenous
levels. Complexes of interest can then be purified via RIPiT. To accumulate
EJC-bound mRNAs, cells can be treated with a translation inhibitor (i.e., cyclo-
heximide) for a short time (1 hour) prior to lysis. EJC-containing mRNPs are
then isolated with an initial IP targeting the FLAG-tagged protein followed by
a second IP using an antibody for a different endogenous EJC protein. Between
the two purification steps, limited RNase I treatment of the precipitated mate-
rial digests unprotected RNA, leaving EJC footprints. The final eluate contains
both the proteins and mRNA regions associated with pre-translational mRNPs
for further study.
The first transcriptome-wide analysis of EJC-associated RNAs confirmed many
known properties of the EJC, and also provided surprising insight into EJC de-
position (Singh et al. 2012). As expected, the EJC footprint is centered around
-24 nt upstream of exon-exon junctions with a width of approximately 14 nt. This
area is referred to as the canonical EJC (cEJC) deposition site. At least 80% of
exon junctions were protected by bound EJCs. GO analysis confirmed mRNAs
with fewer occupied cEJC sites were not tied to any particular gene class. Con-
versely, cEJC occupancy was highly enriched (~8-fold) on mRNAs known to be
regulated by AS-NMD (Section 1.4.1.2). These same transcripts were also more
likely to be bound by EJCs at noncanonical EJC sites (nEJCs) in nearby exonic
locations.
In addition to short (~12-25 nts) footprints at cEJC and nEJC locations, longer
(~30-150 nt) RNA fragments were protected from RNase I digestion even under
very stringent digestion conditions. These longer footprints were associated with
larger complexes that contained both core EJC proteins and other mRNA binding
proteins (Singh et al. 2012). Notably, the broader EJC proteome contained an
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Figure 1.19: RIPiT strategy for isolating EJC-associated mRNPs. Figure from Singh et al. 2012.
Copyright 2012 Elsevier.
unexpected number of SR and SR-like proteins with known functional roles in
splicing, export, and translation (reviewed in Singh et al. 2012). Associations
with these proteins are believed to stabilize the larger EJC interactome that forms
the pre-translational mRNP.
The organization of pre-translational mRNPs was further explored using a modi-
fied version of RIPiT called RIPPLiT for RNA immunoprecipitation and proximity
ligation in tandem (Figure 1.20, Metkar et al. 2018). For RIPPLiT, RNase di-
gestion conditions during the first IP are adjusted to produce a broad fragment
distribution between 30 and >500 nts. During the second IP step, tandem phos-
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phatase and kinase reactions produce 5’ and 3’ ends appropriate for ligation by
T4 RNA ligase 1, which joins spatially-adjacent RNA ends, creating chimeras.
Deep sequencing of the resulting RNA (~200-550 nt fragments) and alignment
of resulting reads to the genome using a custom algorithm, ChimeraTie (Metkar
et al. 2018), revealed the locations of chimeric junctions. For abundant ncR-
NAs with known 3D structures (e.g., contaminating 5.8S, 18S and 28S rRNAs),
these chimeric junctions were consistent with previously determined structures.
On mRNAs, chimeric junctions were exclusively intramolecular and evenly dis-
tributed, even across long exons. No interactions, however, were found between
the 5′ and 3′ ends of mRNAs. Combined with scaling analysis, which examines
the relationship between junction frequency and nucleotide distance, these obser-
vations suggest pre-translational mRNPs form flexible rod-like structures (Figure
1.21).
Figure 1.20: RIPPLiT strategy for capturing pre-translational mRNPs. Yellow/blue: EJC proteins;
grey: non-EJC proteins. Figure from Metkar et al. 2018. Copyright 2018 Elsevier.
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Figure 1.21: Predicted structure of the pre-translational mRNP. Figure from Metkar et al. 2018.
Copyright 2018 Elsevier.
A key control in RIPPLiT-Seq experiments is the construction of libraries from
RNase-treated samples not subsequently incubated with RNA ligase. The EJC
RIPPLiT-Seq study included three (-) ligase control replicates (Metkar et al. 2018).
In my dissertation work, I used these - ligase control libraries, along with published
RNA-Seq libraries (Sultan et al. 2014), for an in-depth exploration of the pre-
translational HEK293 transcriptome. As the median internal human exon length
is 187 nts (Ensembl), the long insert (~200-550 nt) and read (220 nt paired end)
lengths of the (-) ligase libraries were sufficient for quantifying known splicing
events and searching for unannotated ones. Chapter 2 within this disseration
contains the manuscript describing my analysis of these pre-existing libraries to
assess how the pre-translational record differs between EJC RIPPLiT and standard
RNA-Seq.
In addition to this body of work, I also spent a considerable amount of time ana-
lyzing libraries derived RNAs associated with from late-stage spliceosomes. Much
like when isolating EJC-containing mRNPs, the spliceosome was selected for by
first targeting FLAG-tagged Magoh followed by an endogenous core spliceosome
protein. Although this work was not published, early analysis determined that
the spliceosome-associated transcriptome contained numerous examples of previ-
ously unannotated splicing events similar to the pre-translational EJC-associated
transcriptome. Our cursory investigation into this transcriptome and these events
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2.2 Introduction
A central mechanism underlying metazoan gene expression is alternative pre-
mRNA processing, which regulates the repertoire of mRNA isoforms expressed
in various tissues and under different cellular conditions. Extensive deep sequenc-
ing of RNA (RNA-Seq) has revealed that ~95% of human protein-coding genes
are subject to alternative splicing (AS) (Eric T Wang et al. 2008; Pan et al.
2008), with current estimates suggesting ~82,000 different protein-coding mRNA
isoforms generated from ~20,000 protein coding genes (Cunningham et al. 2019).
Thus, production of alternative mRNA isoforms massively expands the protein
repertoire that can be expressed from a much smaller number of genes (Nilsen &
Graveley 2010; Kelemen et al. 2013). But cells also need to control how much
of each protein is made. Although transcriptional control is often considered the
predominant mechanism for modulating protein abundance, emerging evidence
indicates that post-transcriptional regulatory mechanisms are crucial as well.
Not all mRNA variants are protein-coding. Nearly 15,000 human mRNAs in the
Ensembl database (release 93) are annotated as nonsense-mediated decay (NMD)
targets (Cunningham et al. 2019). NMD is a translation-dependent pathway that
both eliminates aberant mRNAs with malformed coding regions (i.e., those con-
taining premature termination codons due to mutation or missplicing) and serves
as a key mechanism for maintenance of protein homeostasis (Kurosaki et al. 2019).
This protein homeostasis function is mediated by AS linked to NMD (AS-NMD),
wherein the flux through alternate splicing pathways that result in protein-coding
and NMD isoforms is subject to tight control (Lewis et al. 2003). These NMD
isoforms harbor a premature termination codon either due to frameshifting or in-
clusion of a poison cassette exon. Because NMD isoforms are rapidly eliminated
after the first or “pioneer” round of translation, only protein-coding isoforms re-
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sult in appreciable protein production (Figure 2.1, bottom). Thus increasing or
decreasing flux through the NMD splicing pathway decreases or increases pro-
tein production, respectively. Although AS-NMD was originally described as a
mechanism by which RNA binding proteins (e.g., SR and hnRNP proteins) could
autoregulate their own synthesis, recent work indicates that AS-NMD is much
more pervasive, tuning abundance of many other proteins such as those involved
in chromatin modification and cellular differentiation (Nasif et al. 2018).
Figure 2.1: (Top) mRNA metabolism from transcription to degradation. In this illustration, poison
exon skipping and inclusion lead to a Protein-coding isoform (grey) and NMD isoform (blue), respec-
tively, with the NMD isoform containing a premature stop codon (red). EJCs (purple) deposited
upstream of exon junctions are cleared by ribosomes during the pioneer round of translation. While
Protein-coding isoforms are subject to multiple rounds of translation prior to decay, NMD isoforms are
rapidly eliminated. (Bottom) Libraries analyzed in this paper: EJC-bound RIPiT-Seq (purple), whole
cell (dark green) and cytoplasmic (light green) RNA-Seq. Colored bars indicate RNA populations
captured in each library type. Figure from Kovalak et al. 2020.
The true extent to which AS-NMD contributes to protein homeostasis can only be
appreciated by determining the flux through the protein-coding and NMD splicing
pathways. Transcriptome-wide assessment of mRNA isoform abundance generally
relies on RNA-Seq of whole cell or cytoplasmic RNA. Such methods provide a static
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snapshot of the species present in the sample at the time of collection. Because
NMD isoforms are so rapidly decayed, they are generally underrepresented in
RNA-Seq datasets. Thus a single RNA-Seq snapshot is generally uninformative
as to synthetic flux through protein-coding and NMD splicing pathways.
An alternate means to assess protein-coding and NMD pathway flux is to capture
newly synthesized mRNAs after splicing completion but prior to translation. Late
in the splicing cycle, the exon junction complex (EJC) is deposited upstream of
at least 80% of exon-exon junctions (canonical; cEJCs) and multiple other sites
throughout the length of spliced exons (noncanonical; ncEJCs) (Singh et al. 2012;
Saulière et al. 2012). Upon nucleocytoplasmic export, the pioneer round of trans-
lation removes EJCs within the 5′ UTR and CDS regions, with EJCs remaining
downstream of stop codons being key mediators of NMD (Maquat et al. 2010).
Pre-translational mRNPs can be selectively isolated by tandem immunoprecipi-
tation of epitope-tagged and untagged EJC components, a technique known as
RNA:protein immunoprecipitation in tandem (RIPiT) (Singh et al. 2014). Deep
sequencing library preparation from RIPiT samples (RIPiT-Seq) has previously
enabled us to map the positions of canonical and noncanonical EJCs on spliced
transcripts (Singh et al. 2012) and to investigate the RNA packing principles
within pre-translational mRNPs (Metkar et al. 2018).
Here, we compare libraries from pre-translational mRNPs (EJC RIPiT), unfrac-
tionated RNA (whole cell RNA-Seq) and RNA post subcellular fractionation (cy-
toplasmic RNA-Seq) (Figure 2.1). As expected, EJC RIPiT libraries are enriched
for transcript isoforms destined for translation-dependent decay. By providing
a window into the repertoire of transcripts generated by splicing but prior to
translation-dependent decay, EJC RIPiT libraries provide a more accurate record
of the flux through various alternative processing pathways than does standard
RNA-Seq. Importantly, EJC RIPiT libraries enabled us to identify numerous new
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evolutionarily-conserved poison cassette exons that had previously eluded annota-
tion based on even highly extensive RNA-Seq data analyses.
2.3 Results
2.3.1 EJC, whole cell and cytoplasmic libraries
In our recent study investigating the organizing principles of spliced RNPs (Metkar
et al. 2018), we generated three biological replicates from HEK293 cells of EJC-
bound RNAs partially digested with RNase T1 during RNP purification (Figure
2.1). Paired-end deep sequencing of these EJC RIPiT libraries resulted in 19-25
million mate pairs each (Table 2.1). For comparison to RNA-Seq libraries, we
chose rRNA-depleted whole cell and cytoplasmic HEK293 RNA-Seq datasets (two
biological replicates each) previously published by Sultan et al. (Sultan et al. 2014).
We chose these particular libraries based on their similarity in cell treatment and
library preparation to our EJC libraries, their clean cellular fractionation, and
sequencing depth (51-57 million mate pairs each).
Table 2.1: Sequencing and alignment information for each replicate of the analyzed libraries. Figure
from Kovalak et al. 2020.
All libraries were downloaded from their respective repositories (see Declarations)
and processed in parallel. Reads were aligned to the Genome Reference Con-
sortium Human Build 38 (GRCh38.p12) (Cunningham et al. 2019) using STAR
(v2.5.3a) (Dobin et al. 2013) after first filtering out those mapping to repeat RNAs.
To minimize the effect of misalignment in ensuing analyses, mismatches were lim-
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ited to three per read, with gaps caused by deletions or insertions being strongly
penalized. These strict mapping parameters resulted in 6-10 million and 30-43 mil-
lion aligned pairs for the EJC RIPiT and RNA-Seq libraries, respectively (Table
2.1). For quantification, we limited all analyses to unique reads with high mapping
quality (MAPQ ≥ 5). For all libraries, we used Kallisto (v0.44.0) to derive expres-
sion values for the ~200,000 annotated transcripts in GRCh38.p12 (Cunningham
et al. 2019). Examination of per-transcript abundance revealed high concordance
(≥ 0.93 to 0.99) among all biological replicates (Figure 2.2). Therefore, all subse-
quent quantitative analyses utilized merged biological replicate data.
Figure 2.2: Scatterplots comparing transcripts per million (TPM) between replicates of the same
library type. R: Pearson’s correlation. Figure from Kovalak et al. 2020.
2.3.2 EJC libraries are enriched for spliced tran-
scripts and translation-dependent decay targets
To assess the relative representation of NMD targets in EJC and RNA-Seq li-
braries, we first examined read coverage on known AS-NMD genes. The SR pro-
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teins TRA2B and U2AF2 negatively regulate their own expression by promoting
inclusion of a highly-conserved poison cassette exon containing a premature termi-
nation codon (Figure 2.3, A-C). Although these poison exons were detectable in
all library types, they were much more abundant in the EJC libraries. As expected
due to NMD, cytoplasmic RNA-Seq libraries exhibited the lowest poison exon in-
clusion (percent spliced in; PSI) values (16% and 4%, respectively), with the whole
cell libraries being somewhat higher (29% and 6%, respectively). Yet, the EJC
RIPiT libraries indicate much higher inclusion percentages (averaging 94% and
73%, respectively). Thus, for both TRA2B and U2AF2, the predominant splicing
pathway in HEK293 cells under standard growth conditions is poison exon inclu-
sion. Similar trends were observed for other known AS-NMD targets (Figure 2.4
and 2.5), including hnRNPA1 where the AS-NMD isoform results from splicing in
the 3′UTR as a consequence of alternative polyadenylation (Figure 2.4, A). The
substantial differences between the EJC RIPiT and RNA-Seq quantitations for
these previously documented AS-NMD isoforms clearly illustrate the advantage
provided by the EJC RIPiT libraries for more accurately assessing flux through al-
ternative processing pathways that result in mRNA isoforms with widely different
decay rates.
In GRCh38.p12, every transcript isoform is given a specific annotation; relevant
annotations in protein-coding genes are “protein-coding”, “NMD”, “NSD”, “re-
tained intron”, and “processed transcript”, with the latter being a catch-all for
transcripts not clearly attributable to any other category. NSD (non-stop decay) is
another translation-dependent mRNA degradation pathway that eliminates tran-
scripts having no in-frame stop codon (Klauer & Hoof 2012). When exported to
the cytoplasm, transcripts containing one or more retained introns are also usu-
ally subject to translation-dependent decay due to the presence of in-frame stop
codons in intronic regions. For transcripts detectable in our libraries [TPM >0
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Figure 2.3: Genome browser tracks of library coverage across individual genes (grey: protein-coding
isoform(s); blue: NMD isoform) containing poison cassette exons (A, TRA2B; B, U2AF2; C, SRSF6).
Shown are all three EJC RIPiT replicates and replicate 1 for whole cell and cytoplasmic RNA-Seq.
Conservation tracks show phyloP basewise scores derived from Multiz alignment of 30 vertebrate
species. Numbers below tracks indicate mean reads per million (RPM) spanning each exon junction.
Numbers to right in B and C are percent spliced in (PSI) values for poison exon inclusion events;
PSI values for RNA-Seq libraries are replicate means. R: Pearson’s correlation. Figure from Kovalak
et al. 2020.
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Figure 2.4: Genome browser tracks of library coverage across individual genes (grey: protein-coding
isoform(s); blue: NMD isoform) containing 3’ UTR introns (A, hnRNPA1; B, PRPF4B).
Figure 2.5: Genome browser tracks of library coverage across individual genes (grey: protein-coding
isoform(s); blue: NMD isoform) containing an exon skipping event.
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in all replicates of a particular library type (EJC, whole cell or cytoplasmic)],
the number of exon junctions (i.e., positions at which introns were removed) per
protein-coding and NMD isoform ranged from 0 to >100 and 1 to 69, respectively
(Figure 2.6A). As expected, protein-coding isoforms having no exon junctions were
less abundant in the EJC libraries than in either RNA-Seq library (Figure 2.6B,
top). In contrast, spliced protein-coding isoforms containing 5 or more exon junc-
tions were enriched in EJC libraries, with the degree of enrichment increasing
with exon junction number. For each exon junction number bin (i.e., 1-4, 5-10
and 10+), NMD isoforms were even more enriched in EJC libraries than were
protein-coding isoforms (Figure 2.6B, bottom). EJC library enrichment was also
readily discernible in per-transcript scatter plots for NMD, NSD, retained intron,
and processed transcript isoforms (Figure 2.7). All of these observations are consis-
tent with the notion that EJC-associated RNAs are enriched for spliced transcripts
subject to subsequent elimination by translation-dependent decay.
Because they are not translated, long intergenic non-coding RNAs (lincRNAs) are
not subject to translation-dependent decay. As expected, lincRNAs lacking exon
junctions (e.g., MALAT1, RMRP, NEAT1 and NORAD) were substantially de-
pleted from EJC libraries, whereas those containing exon junctions were of similar
or higher abundance in EJC than RNA-Seq libraries (Figure 2.8). Particularly no-
table was XIST, the most highly represented Pol II transcript in our EJC libraries
(Metkar et al. 2018). XIST is both spliced and exclusively nuclear. Reflecting
this, median abundance of the eight major XIST isoforms was five- and forty-fold
greater in EJC than in whole cell and cytoplasmic libraries, respectively.
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Figure 2.6: (A) Distribution of the number of exon junctions in all annotated protein-coding (grey)
or NMD (blue) transcripts. (B) Distribution of protein-coding (top) and NMD (bottom) transcripts
per million (TPM) in each library type (colors as in Figure 1A), binned based on indicated number
of exon junctions per transcript. Results of one-way ANOVA and Tukey’s post hoc significance tests
comparing EJC RIPiT-Seq to RNA-Seq libraries are indicated: *P<0.05, **P<0.01, ***P<0.005,
****P<0.0001. Figure from Kovalak et al. 2020.
2.3.3 EJC libraries capture new exon junctions
Having established that spliced transcripts known to be eliminated by translation-
dependent decay are enriched in EJC libraries, we next wondered whether EJC li-
braries might contain new transcript isoforms that had previously eluded detection
due to their low abundance in RNA-Seq. Such isoforms should contain previously
unannotated exon junctions. To identify all previously annotated exon junctions,
we integrated the RefSeq (hg38) (O’Leary et al. 2016), Ensembl (GRCh38.p12)
(Cunningham et al. 2019), GENCODE (v29) (Frankish et al. 2019) and Compre-
hensive Human Expressed SequenceS (CHESS) transcriptome annotations to
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Figure 2.7: Scatterplots comparing TPMs between EJC RIPiT-Seq and whole cell or cytoplasmic
RNA-Seq libraries for different isoform types: Protein-coding (A/B, left), NMD (A/B, right), non-
stop decay (C/D, left), retained intron (C/D, middle), and processed transcript (C/D, right). In (A
and B), transcripts from Figure 2.3 and 2.4 are noted. N: Number of detected transcripts out (of
all annotated transcripts of that type). Dashed black line is the x=y line. Figure from Kovalak et al.
2020.
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Figure 2.8: Scatterplots comparing TPMs between EJC RIPiT-Seq and whole cell (A) or cytoplasmic
(B) RNA-Seq libraries for lincRNAs. O and X indicate spliced and unspliced lincRNA transcripts,
respectively; XIST isoforms are indicated as open black circles. N: Number of detected transcripts
out (of all annotated transcripts of that type). Dashed black line is the x=y line. Figure from Kovalak
et al. 2020.
create a comprehensive reference file containing 575,976 known introns. CHESS is
derived from 9,795 RNA-Seq samples from diverse cell types in the GTEx collec-
tion, so represents the most complete compendium of human transcripts reported
to date (Pertea et al. 2018). Yet while CHESS found 118,183 new exon junctions
not previously annotated in RefSeq, Ensembl or GENCODE, 82,918 other junc-
tions present in RefSeq, Ensembl and/or GENCODE were not returned by the
CHESS pipeline (Figure 1.15). This lack of concordance with respect to anno-
tated junctions shows that even the most comprehensive RNA-Seq data analyses
are unlikely to capture all bona fide splicing events.
To identify annotated and unannotated exon junctions in our EJC, whole cell and
cytoplasmic libraries, we considered only those reads that cross an exon junction.
The position of an exon junction in an individual read can be found by examining
the “N operation” in the CIGAR string, which indicates the locations and lengths
of gaps inserted during alignment to genomic DNA (Figure 2.9). We further re-
quired that any candidate junction: (1) occur within an annotated gene; (2) have
reads with ≥ 15 nt aligning on both sides of the junction (≥ 90% exact sequence
match on each side); (3) be detectable in all replicates of a particular library type
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(EJC, whole cell or cytoplasmic); and (4) have a mean read count ≥ 2 per library
type (Figure 2.9). Using these criteria, we identified 151,072 junctions contained
in the RefSeq/Ensembl/GENCODE/CHESS reference file (annotated junctions)
and 5,917 previously unannotated junctions. MEME analysis of the latter revealed
the 5′ and 3′ splice site consensus motifs for the major spliceosome, although at
somewhat lesser strength (bits) than annotated junctions (Figure 2.10A). To limit
our analysis to events most likely representing real splicing events (as opposed to
mapping artifacts), we subsequently only considered the 5,412 previously unan-
notated junctions where the putative intron began and ended with dinucleotides
expected for either the minor (AT-AC) or major (GT-AG) spliceosome. Of these,
only three had AT-AC termini, indicating that the vast majority (>99.9%) of the
unannotated events we detected are due to intron excision by the major spliceo-
some.
The majority (73%) of previously-annotated exon junctions meeting our detection
criteria in protein coding genes (Figure 2.9) were present in all three library types
(Figure 2.10B, left). There was less concordance, however, with respect to unanno-
tated junctions, with the EJC libraries having many more unannotated junctions
than either whole cell or cytoplasmic RNA-Seq (Figure 2.10B, right). Consistent
with the expectation that EJC libraries should be enriched for exon junctions, both
annotated and unannotated junctions were supported by more reads per million
mapped (RPM) in the EJC libraries (Figure 2.11A). Also as expected, annotated
junctions were generally supported by more reads than unannotated junctions in
all library types. The major class (49%) of the new junctions were new alterna-
tive 5′ or 3′ splice sites (i.e., that combined a known 3′ or 5′ splice site with a
previously unannotated 5′ or 3′ splice site, respectively) (Figure 2.11B). Other
categories were previously unannotated exon skipping events (34%), new cassette
exons (14%) and new introns (4%).
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Figure 2.9: Schematic of library processing steps used to identify and analyze reads at annotated and
unannotated junctions. Full details of each step are explained within the section above. Figure from
Kovalak et al. 2020.
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Figure 2.10: (A) Sequence motifs for 5’ (left) and 3’ (right) splice sites used in annotated junctions
observed in at least one analyzed library type (top) and for previously unannotated splice sites in
indicated library type (bottom). Sequence logos were generated in R using ggseqlogo; letter height
signifies the relative abundance of that nucleotide at each position. N: Number of splice sites
contributing to each logo. Note that the number of unannotated junctions (5,917) is greater than the
total number of unannotated splice sites because many unannotated junctions combine an annotated
and unannotated splice site (i.e., alternative 5′ or 3′ splice sites). (B) Venn diagram of annotated and
previously unannotated junctions (numbers indicated) shared between library types. Venn diagrams
made with eulerr. Figure from Kovalak et al. 2020.
Figure 2.11: (A) Cumulative histogram of exon junction reads (RPM) at annotated (X) and previously
unannotated (O) junctions in each library type (colors as in Figure 1A). (B) Schematic of unannotated
splicing events separated by event type: Skipped exon (red); alternative 3′ (orange) or 5′ (yellow)
splice site; new intron (light blue); new cassette exon (dark blue). N: number of observed events; for
new cassette exons, both the number of observed unannotated junctions and number of new exons
are shown. Figure from Kovalak et al. 2020.
2.3.4 Relationship of new splicing events to reading
frame
Previous analyses of low abundance, unannotated splicing events in RNA-Seq data
have revealed a strong tendency for such events to maintain reading frame (Dou et
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al. 2006; Pickrell et al. 2010). To investigate whether this is due to some inherent
ability of the splicing machinery to detect reading frame in the nucleus (Wachtel
et al. 2004), or simply due to translation-dependent decay of out-of-frame events
in the cytoplasm, we determined the distance from each previously unannotated
splice site meeting our selection criteria to the nearest annotated splice site ob-
served in any of our three library types. In all, 126 and 273 unannotated 5′ and 3′
splice sites, respectively, occurred within 15 nts of an annotated 5′ or 3′ splice site.
Comparison of unannotated-to-annotated splice site distance aggregation plots
between the three library types revealed both similarities and differences (Figure
2.12A). Around annotated 5′ splice sites, all three libraries displayed similar pat-
terns, with the greatest unannotated usage being at intron position +5, consistent
with the preference for a G and a T at positions +5 and +6, respectively, in the
human 5′ splice site consensus sequence (Figure 2.10A) and the prevalence of GT
dinucleotides at this position in this set of 126 5′ splice sites (dotted gray line in
Figure 2.12A). More notable was the pattern near 3′ splice sites, where positions
+3 and +4 in the downstream exon exhibited the highest unannotated usage. Strik-
ingly, whereas the RNA-Seq libraries were strongly skewed toward position +3,
both positions +3 and +4 in the EJC libraries were highly represented, with their
usage closely reflecting the number of available AG’s at these positions (dotted
gray line in Figure 2.12A). Comparison of fractional abundance [unannotated read
counts/(unannotated + annotated read counts)] at individual sites confirmed that
whereas the EJC and RNA-Seq libraries exhibited similar utilization at position
+3, utilization of position +4 was much more prominent in the EJC than either
RNA-Seq library (Figure 2.12B). These observations strongly support a model in
which out-of-frame splicing events are rapidly eliminated by NMD, resulting in
their underrepresentation in both whole cell and cytoplasmic RNA-Seq libraries.
Because utilization of AGs at positions +3 and +4 in the EJC libraries so closely
paralleled their availability, we conclude that (at least with regard to 3′ splice
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sites) the splicing machinery has no ability to read frame.
Figure 2.12: (A) Distribution of of unannotated splice sites relative to the closest annotated splice
site observed in analyzed libraries (solid colored lines). Grey dotted line: Frequency of available GT
or AG dinucleotides surrounding the annotated 5’ (left) and 3’ (right) splice sites with open circles
indicating in-frame positions and solid grey dots indicating out-of-frame positions. (B) Distribution
of the ratio of unannotated alternative 3’ splice site use (RPMUnanno) over all events using the
same 5’ splice site (RPMUnanno+ RPMAnno) in each library type. (Left) Unannotated alternative
3’ splice sites at the +3 position relative to closest annotated 3′ splice site; (middle) same but at the
+4 position. Grey lines show how the top 20 percent (highest RPMUnanno) of unannotated junctions
detected in EJC RIPiT-Seq libraries differ between library types. Results of one-way ANOVA and
Tukey’s post hoc tests comparing EJC RIPiT-Seq to RNA-Seq libraries are indicated; ****P<0.0001.
(Right) Median (RPMUnanno/(RPMUnanno+ RPMAnno)) values per library at the +3 and +4
positions. Figure from Kovalak et al. 2020.
2.3.5 Evolutionary conservation versus splicing noise
Regardless of reading frame, most unannotated splicing events are likely due to
“splicing error” (Fox-Walsh & Hertel 2009) or “splicing noise” (Pickrell et al. 2010).
Splicing noise results from spurious utilization of cryptic splice sites that are not
evolutionarily conserved. To assess both evolutionary conservation and splice site
strength, we calculated mean basewise phyloP 30-way vertebrate conservation
(Pollard et al. 2010) and MaxENT (a generally accepted measure of how well a
particular splice site matches the consensus) (Yeo & Burge 2004) scores for both
annotated and unannotated splice sites, using the same 5′ and 3′ splice site window
sizes (9 and 23 nts, respectively) for both calculations (Figure 2.13). We also
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Figure 2.13: Regions used to calculate MaxEnt and mean conservation scores surrounding unanno-
tated alternative 3’ and 5’ splice sites and new introns (top) or new cassette exons (bottom). Figure
from Kovalak et al. 2020.
calculated conservation and MaxENT scores for sequences chosen at random from
inside annotated genes and containing either GT or AG at the appropriate position
within the 5′ or 3′ splice site window, respectively. Plotting MaxENT versus con-
servation revealed markedly different distributions between annotated splice sites
and random GT- and AG-containing sequences (Figure 2.14A, Figure 2.16), with
annotated sites being significantly skewed toward higher values for both measures.
In contrast, whereas unannotated splice sites were similarly distributed as anno-
tated splice sites with regard to MaxENT, the majority exhibited conservation
scores more similar to random than annotated splice sites (Figure 2.14B). For the
random sequences, 95% had 5′ and 3′ splice site conservation scores below 1.03 and
0.63, respectively. Using these values as cutoffs to filter out the majority of events
likely due to splicing noise (although this may be unnecessarily conservative for 3′
splice sites due to the high degree of overlap between the annotated and random
conservation scores) left us with 252 (12%) and 630 (26%) evolutionarily-conserved
unannotated 5′ and 3′ splice sites, respectively. The majority of these occurred
within annotated protein-coding exons, so their conservation is likely driven by
amino acid conservation and not as a requirement for recognition by the splicing
machinery (see Figure 2.17A for an example). Almost all of the new evolutionarily
conserved introns (i.e., both the 5′ and 3′ splice sites were previously unannotated,
but exhibited high conservation) also fell into this category. For the new introns,
calculation of percent intron retention (PIR) in the EJC libraries revealed highly
82
inefficient splicing (mean PIR = 0.93), and individual examination of those ex-
hibiting the highest number of exon junction reads in the EJC libraries led to no
findings of particular note. Thus the new introns likely constitute splicing noise
due to low level spliceosome assembly on sites within exons that by happenstance
resemble splice site consensus sequences. In contrast, examination of unannotated
3′ splice sites occurring within introns uncovered a conserved alternative splicing
event in the HECTD4 (HECT domain E3 ubiquitin protein ligase 4) gene that
adds 9 amino acids into the middle of the protein (Figure 2.17B); this spliced iso-
form is currently annotated in mouse RefSeq and GENCODE, but not in humans.
Other alternative 3′ splice sites in the CNOT1 and EEA1 genes generate AS-NMD
isoforms (Figure 2.15), the latter due to creation of a new poison cassette exon.
2.3.6 New evolutionarily-conserved poison cassette ex-
ons
Having found examples of new AS-NMD isoforms generated by unannotated 3′
splice sites, we were interested to investigate which of the new cassette exons iden-
tified here might also function in this capacity. Of the 445 new cassette exons (Fig-
ure 2.11A), 412 (93%) occurred in protein-coding genes; the remainder occurred in
pseudogenes and ncRNAs. Based on the data in Figure 2.3, poison exons should
exhibit higher abundance in EJC than in RNA-Seq libraries. Consistent with this,
315/412 (76%) were solely detectable in the EJC libraries, with the remainder
averaging 12- and 13-fold higher abundance in the EJC libraries than in whole
cell or cytoplasmic RNA-Seq, respectively (Figure 2.18). Of the 377 new cassette
exons detectable in EJC libraries, 70% were frameshifting (i.e., not a multiple of 3
nts long). Individual inspection of the 25 most abundant non-frameshifting exons
revealed that 80% contained an in-frame stop codon. Therefore, as expected, the
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vast majority of new exons likely function as poison cassette exons.
Figure 2.14: Scatterplots comparing MaxEnt scores to mean conservation scores (phyloP, 30-way)
at 5’ (left) or 3’ (right) splice sites for (A) annotated and random or (B) observed unannotated
events. Smaller points are used to represent splice sites with either score lower than 0 as these may
result from splicing noise. Annotated splice sites were downsampled by randomly selection (5’, N
= 2,048; 3’, N = 2,456; same as unannotated splice site numbers in C) from the 151,072 observed
in our libraries. Figure 2.11A shows the same plot for all observed annotated splice sites. (A) also
contains 2,048 random GT-containing (left) and 2,456 random AG-containing (right) sites; identical
plots for four additional sets of randomized locations are shown in Figure 2.16A. The top 5 percent
mean conservation scores of random sites is indicated and marked by a dashed line. Genes for which
genome-browser tracks are shown in Figure 2.15 and Figure 2.17 are indicated. Figure from Kovalak
et al. 2020.
84
Figure 2.15: Genome browser tracks of library coverage across CNOT1 (A) and EEA1 (B). Annotated
transcripts are shown in grey and unannotated alternative 3′ splice site use in orange. Conservation
tracks and annotations are as in Figure 2.3. Figure from Kovalak et al. 2020.
To assess whether any of the new cassette exons constitute conserved regulatory
elements, we calculated mean phyloP 30-way conservation scores across the entire
exon. Combining these exon conservation scores (white to dark blue in Figure
2.19) with the previously calculated 5′ and 3′ splice site conservation scores (Figure
2.14A) revealed a set of 20 previously unannotated cassette exons exhibiting both
high internal (phyloP score ≥ 1) and high splice site (≥ 1 for both splice sites)
conservation (Figure 2.19 right). Among these, the most highly represented in our
datasets was a new 94 nt exon within intron 8 of the 22-intron protein tyrosine
phosphatase, receptor type A (PTPRA) gene (Figure 2.20A). Reminiscent of the
conserved poison exons in TRA2B and U2AF2 (Figure 2.3A and B), inclusion of
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Figure 2.16: (A) Scatterplots comparing the MaxEnt score to mean conservation score (phyloP, 30-
way) at 5’ (left) or 3’ (right) splice sites for all annotated junctions (N = 151,072). (B) Scatterplots
comparing the MaxEnt score to conservation (phyloP, 30-way) at 5’ (left) or 3’ (right) splice sites for
multiple sets (N = 5) of randomly selected sequences (5’, N = 2,048; 3’, N = 2,456). Figure from
Kovalak et al. 2020.
Protein Tyrosine Phosphatase Receptor Type A (PTPRA) exon 8a was readily
observable in the EJC libraries, but nearly undetectable in the RNA-Seq libraries
(Figure 2.20A). Other high abundance examples were a 103 nt exon in intron 3 of
the 29-intron DNA Polymerase Theta (POLQ) gene (Figure 2.21) and a 69 nt
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Figure 2.17: (A) Genome browser tracks of library coverage across HSPA8 (C) and HECTD4 (D).
Annotated transcripts are shown in grey, unannotated alternative 3’ splicing events in orange, and
unannotated introns in light blue. Conservation tracks represent phyloP basewise scores derived from
Multiz alignment of 30 vertebrate species, as well as 100 vertebrate species in (B). Numbers below
tracks indicate mean reads per million (RPM) spanning each exon junction. Numbers to right in C
and D are percent intron retention (PIR) and percent spliced in (PSI) values, respectively; PSI and
PIR values for RNA-Seq libraries are replicate means. The translated protein sequences of both the
annotated and unannotated transcripts are provided in (D). Figure from Kovalak et al. 2020.
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exon in intron 37 of the 39-intron pleckstrin homology domain interacting protein
(PHIP) gene (Figure 2.20B). Although PHIP exon 37a does not frameshift, it
does contain three highly-conserved in-frame stop codons (Figure 2.20B, bottom).
Thus all of the new evolutionarily-conserved cassette exons identified here likely
function as poison exons to regulate protein expression from their host gene.
Figure 2.18: Density plot comparing junction-spanning read coverage (RPM) for new cassette exons in
EJC and RNA-Seq libraries. Line indicates median expression per library and dots represent individual
cassette exons. N: number of observed cassette exons per library. Figure from Kovalak et al. 2020.
Figure 2.19: (A) (Left) Scatterplot comparing mean conservation (phyloP, 30-way) at 5’ and 3’ splice
sites of new cassette exons. Exons with scores above 0 at both splice sites are colored (white to
dark blue) to indicate mean exon conservation and sized by the number of junction-spanning reads
supporting that exon in EJC RIPiT-Seq libraries. Diamonds indicate exons that create a frameshift
in the resulting mRNA; circles indicate non-frameshifting exons. (Right) Zoomed view of exons with
mean 5’ and 3’ splice site conservation scores above 1.03 and 0.63, respectively. Figure from Kovalak
et al. 2020.
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Figure 2.20: Genome browser tracks of library coverage across new poison cassette exons in PHIP (A)
and PTPRA (B). New cassette exons are shown in blue and numbered according to their placement
in the major isoform observed in all libraries. Conservation tracks and annotations are as in Figure
2.3. Figure from Kovalak et al. 2020.
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Figure 2.21: Genome browser tracks of library coverage across new poison cassette exons in POLQ.
New cassette exons are shown in blue and numbered according to their placement in the major
isoform observed in all libraries. Conservation tracks and annotations are as in Figure 2.3. Figure
from Kovalak et al. 2020.
2.4 Discussion
Here we demonstrate that deep sequencing of transcripts in pre-translational
RNPs provides a means to identify/quantify mRNA isoforms underrepresented
in or absent from RNA-Seq libraries due to their rapid elimination by translation-
dependent mRNA decay. We captured this pre-translational population by tan-
dem immunoprecipitation (RIPiT) (Singh et al. 2014) of two core EJC proteins.
EJCs are stably deposited upstream of exon junctions late in the pre-mRNA splic-
ing process, and EJCs in 5′ UTRs and coding regions (~98% of all) are neces-
sarily removed during the first or “pioneer” round of ribosome transit. Thus the
EJC provides an excellent handle by which to enrich for fully-processed, but not-
yet-translated mRNAs (Figure 2.1). Because they are specifically enriched for
spliced transcripts, EJC RIPiT-Seq libraries also better capture low abundance
splicing events than traditional RNA-Seq libraries. This enabled us to identify
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thousands of new exon junctions not currently annotated in any of four major
reference datasets based on RNA-Seq. Many of these new splicing events gener-
ate isoforms subject to NMD, with some being evolutionarily-conserved AS-NMD
regulatory events. Thus EJC RIPiT-Seq constitutes a useful method to query the
spliced transcriptome without the confounding effects of differential translation-
dependent decay of individual mRNA isoforms.
2.4.1 Flux through AS-NMD pathways
Since its initial description (Morrison et al. 1997; Mitrovich & Anderson 2000),
AS-NMD has increasingly emerged as a key post-transcriptional regulatory mech-
anism (Zheng et al. 2012; Hamid & Makeyev 2014; Yan et al. 2015). Due to their
widely different decay rates, however, the flux through the alternative processing
pathways resulting in protein-coding and NMD isoforms cannot be determined
by traditional RNA-Seq methods. As shown in Figure 2.3 the vast majority of
TRA2B (A) and U2AF2 (B) transcripts present in RNA-Seq libraries are the pro-
tein coding isoforms. Further, the lower poison exon PSI numbers in cytoplasmic
than whole cell libraries are consistent with cytoplasmic decay of the NMD iso-
forms. The EJC RIPiT-Seq libraries, however, tell a very different story. For both
TRA2B and U2AF2, the predominant pre-translational isoform is the poison-exon-
included isoform, with poison exon PSIs averaging 94 and 73, respectively. Thus
alternative splicing flux for both genes strongly favors poison exon inclusion. Sim-
ilar results were observed for other RNA-binding protein genes known to maintain
protein homeostasis by AS-NMD (Figures 2.3, 2.3, and 2.5). Indeed, enrichment
of transcripts subject to translation-dependent decay (e.g., isoforms annotated as
NMD and NSD) is a general feature of our EJC RIPiT libraries (Figures 2.7 and
2.8). We note, however, that to increase the abundance of pre-translational RNPs,
we exposed our HEK293 cells to 2 mg/ml harringtonine for 60 minutes prior to cell
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harvest and lysis (Metkar et al. 2018). At least in yeast growing under suboptimal
conditions, inhibition of translation can induce rapid transcriptional upregulation
of genes involved in ribosome biogenesis (Santos et al. 2019); the extent to which
this is also true in mammalian cells growing under optimal conditions, and whether
transcription and pre-mRNA processing of other gene classes are affected, has yet
to be thoroughly explored. One recent study in HeLa cells, however, showed that,
whereas a 15 minute exposure to 100 mg/ml cycloheximide had almost no effect on
mRNA abundance in whole cell RNA-Seq, multiple mRNAs encoding ribosomal
proteins decreased in abundance after a 24 hour cycloheximide treatment (i.e., the
opposite of yeast) (Kearse et al. 2019). Because any transcriptional effects would
confound the analysis, elimination of translation inhibitors would be advisable for
any future EJC RIPiT-Seq study specifically aimed at quantifying flux through
alternative RNA processing pathways in non-perturbed cells.
2.4.2 Identification of novel conserved splicing events
A major goal for this study was to assess the utility of EJC RIPiT-Seq libraries
for identifying novel sites of exon ligation that are underrepresented in traditional
RNA-Seq libraries. These could be splicing events resulting in either stable, low
abundance isoforms or highly unstable transcripts such as NMD and NSD sub-
strates. As illustrated in Figure 1.15, even the deepest analysis of RNA-Seq to
date (CHESS) failed to capture all of the exon ligation events annotated in Ref-
Seq, Ensembl or GENCODE. CHESS combined data from 9,795 GTEx RNA-Seq
libraries covering dozens of tissues and comprising just under 900 billion reads.
Yet EJC RIPiT-Seq libraries from a single cell type grown under a single con-
dition encompassing only ~60 million reads enabled us to identify thousands of
new exon junctions not currently annotated in RefSeq, Ensembl, GENCODE or
CHESS (Figure 2.10B). Whereas the majority of these events occur at sites lack-
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ing splice site conservation and so likely constitute splicing noise, hundreds exhibit
high sequence conservation among mammals. Among this conserved set, the ma-
jority display features expected to generate an AS-NMD isoform (i.e., frameshift
or in-frame stop codon).
2.4.3 New poison exons regulate genes linked to cancer
It has now been well established that changes to pre-mRNA splicing patterns can
drive cancer initiation and progression (Sveen et al. 2016; Climente-González et
al. 2017). Thus it is of particular note that three of the most conserved, high-
abundance AS-NMD events discovered here are poison cassette exons in PTPRA,
PHIP, and POLQ (Figure 2.20 and 2.21). All three genes have been linked to poor
cancer prognosis when overexpressed (Tabiti et al. 1995; Ardini et al. 2000; Gu
et al. 2017; De Semir et al. 2012; Wood & Doublié 2016; Goullet de Rugy et al.
2016). While protein overexpression in cancer often results from gene duplication
or transcriptional dysregulation, decreased flux through a splicing pathway leading
to poison exon inclusion would have the same effect. Previous studies examining
the links between NMD and cancer have mainly focused on loss of tumor suppres-
sor genes due to increased NMD (Lindeboom et al. 2016; Hu et al. 2017) or the
advantageous effects of NMD in eliminating mRNA isoforms encoding neoepitopes
that would otherwise be recognized by the immune system (Pastor et al. 2010).
But our findings suggest that decreased poison exon inclusion should also be con-
sidered as a contributor to the mechanisms underlying cancer. An obvious means
to alter splicing flux is a cis-acting mutation that disrupts splice site recognition
and, thereby, poison exon inclusion. Although our examination of The Cancer
Genome Atlas (Release 19) database (Weinstein et al. 2013) revealed no instances
of splice site mutations associated with any of the new conserved poison cassette
exons documented here, this possibility should certainly be considered in future
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hunts for cancer-promoting mutations. Of note, current “exome” sequencing gen-
erally captures only DNA covering and surrounding annotated exons (Wang et
al. 2018). Therefore, the unannotated cassette exons we identify here are likely
absent from most DNA sequencing databases.
2.4.4 Conclusions
Sequencing of post-splicing, pre-translational mRNPs provides a powerful new ap-
proach to identify and quantify transient species that undergo rapid translation-
dependent decay and are therefore under-represented in or completely absent from
standard RNA-Seq libraries. The data here constitute just one snapshot of AS
flux in HEK293 cells growing under optimal conditions. Future studies examining
EJC RIPiT-Seq libraries from more diverse biological samples will undoubtedly
lead to discovery of even more previously undocumented AS-NMD pathways. Ex-
amination of how flux through such pathways change in response to changing cellu-
lar conditions will increase our general understanding of how post-transcriptional
mechanisms regulate protein abundance.
2.5 Availability of data and materials
The RIPiT datasets analyzed in this study were downloaded from NCBI
GEO under accession number GSE115788 (specifically, samples GSM3189985,
GSM3189986, and GSM3189987). RNA-Seq datasets were downloaded from the
European Nucleotide Archive under accession number PRJEB4197 (specifically,
runs ERR304485, ERR304486, ERR304487, and ERR304488).
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2.7 Methods
2.7.1 Deep sequencing libraries
All libraries were downloaded from the NCBI GEO GSE115788 (specifically, sam-
ples GSM3189985, GSM3189986, and GSM3189987) and the European Nucleotide
Archive PRJEB4197 (specifically, runs ERR304485, ERR304486, ERR304487,
and ERR304488).
EJC libraries were generated from 200-550 nt fragments by 3′ adaptor ligation
and reverse transcription. Paired-end sequencing (150 nt reads) on the Illumina
NextSeq platform resulted in 18-24 million mate pairs per replicate (Metkar et al.
2018). RNA-Seq datasets were obtained by paired-end sequencing (51 nt reads)
on the Illumina HiSeq platform of Ribo-Zero-treated libraries generated with a
modified Illumina TruSeq protocol (Sultan et al. 2014) containing 100 to 200 nt
sized inserts. Each RNA-Seq replicate contained an average of 50 to 60 million
mate pairs per library.
2.7.2 Library processing and alignment
Read counts for unprocessed libraries and for the individual processing steps de-
tailed below are provided in Table 2.1. Prior to alignment, adaptor sequences
and long stretches (≥ 20 nt) of adenosines were trimmed from the 3′ end of se-
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quencing reads. All libraries were filtered using STAR v2.5.3a (Dobin et al. 2013)
for reads that aligned to repeat regions, as defined by RepeatMasker. Remaining
reads were aligned with STAR on two-pass mode to the human genome, release 93
(Cunningham et al. 2019). This alignment allowed a maximum of 3 mismatches
per pair and highly penalized deletions and insertions. Mapped reads were then
filtered for low mapping quality (MAPQ < 5) and/or duplicated reads, identified
with the MarkDuplicates tool (Picard v2.17.8).
2.7.3 RNA isoform quantification
RNA isoform abundances were determined using Kallisto (v0.44.0) (Bray et al.
2016), using only reads that passed the filtering and alignment steps described
above. Transcript biotypes (i.e., “protein-coding”, “nonsense-mediated decay”,
etc.) and intron counts used to categorize transcripts throughout Figure 2 are
based on the transcriptome annotation from Ensembl (GRCh38.p12) (Cunning-
ham et al. 2019).
2.7.4 Junction identification pipeline
The custom bioinformatics pipeline designed for our annotated and unannotated
junction analysis is shown in detail in Figure 2.9. Transcriptome annotation files
from RefSeq (hg38) (O’Leary et al. 2016), Ensembl (GRCh38.p12) (Cunningham
et al. 2019), GENCODE (v29) (Frankish et al. 2019), and CHESS (v2.1) (Pertea
et al. 2018) were combined to create a comprehensive reference file of all annotated
introns. Any junction that appears in our libraries but is not annotated in one of
the aforementioned transcriptomes is referred to as “unannotated.”
To identify unannotated exon junctions, all reads with CIGAR strings containing
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an “N” operation were isolated and then compared to the annotated intron ref-
erence file using Bedtools intersect (Quinlan & Hall 2010). Reads that did not
match the length or location of a known intron were considered the result of po-
tential unannotated splicing events. These junctions were further filtered based
on the following criteria: (i) overlap with a known gene, (ii) reads must have ≥ 15
nt aligned on both sides of the potential junction, (iii) present in all replicates of
any library type, (iv) major spliceosome dinucleotide consensus sequences at the
5′ and 3′ splice sites, and (v) mean read count ≥ 2 per library type.
2.7.5 Nearest annotated splice site analysis
For analysis of new splicing events near annotated exons (Figure 2.12), each unan-
notated 5′ splice site was paired with its nearest annotated 5′ splice site based on
the 3′ splice site used in both splicing events. Similarly, each unannotated 3′ splice
site was paired with its nearest annotated 3′ splice site based on the 5′ splice site
used in both splicing events. The number of available GT and AG dinucleotides
at nucleotide positions -30 to +30 surrounding each annotated splice site in this
unannotated/annotated paired dataset.
2.7.6 Splice site strength and conservation
Splice site strength and mean conservation scores for annotated and unannotated
splice sites were calculated using MaxEntScan (Yeo & Burge 2004) and phyloP
30-way basewise conservation scores (Pollard et al. 2010) (Figure 2.13). Random
sequences of the appropriate length (9 nts for 5′ splice sites and 23 nts for 3′ splice
sites) and internal to annotated genes were obtained from the hg38 annotation
file (Cunningham et al. 2019) using the Bedtools random function (Quinlan &
Hall 2010). Only those random sequences containing a GT at positions 4 and 5 or
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an AG at positions 19 and 20 were used to calculate MaxENT and conservation
scores for comparison to 5′ and 3′ splice sites, respectively.
2.7.7 Plotting and data visualization
Data visualization was performed in R using ggplot2, ggrepel, UpSetR, ggseql-
ogo, eulerr, and ggridges software packages. The UCSC Genome Browser was







The contents of this Chapter have not been published previously and contain work
completed during the first half of my doctoral research.
3.2 Introduction
Commitment of a pre-mRNA to a specific splicing pattern represents a critical step
for regulation of alternatively spliced transcripts. Data suggests that commitment
occurs in two phases for both constitutively and alternatively spliced substrates
(Lim & Hertel 2004; Kotlajich et al. 2009). The first phase, commitment to
splicing, is thought to occur upon E complex formation. In vitro chase experiments,
in which stalled spliceosomes were first incubated with radiolabeled pre-mRNAs,
and then chased with an excess of unlabeled pre-mRNAs, demonstrated that pre-
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mRNAs bound by E complexes eventually spliced while naked transcripts did
not (Legrain et al. 1988; Seraphin & Rosbash 1989). E complexes purified from
mammalian cell extracts behaved similarly (Michaud & Reed 1991).
These early spliceosomes, however, have not yet committed to specific splice sites.
In vitro kinetic trapping experiments, in which spliceosomes are stalled in the
desired complex by altering buffer conditions, revealed that trapped E complexes
could change splice sites when incubated with purified SR proteins (Lim & Hertel
2004; Kotlajich et al. 2009). Nevertheless, the addition of SR proteins did not
affect the splicing pattern after U2 snRNP began assembly near the 3′ splice
site. These results suggest that the formation of the first ATP-dependent complex
commits the spliceosome to the chosen splice sites. It follows then that alternative
splicing patterns must be decided early in the assembly pathway.
However, more recent single molecule experiments indicate that many spliceosome
assembly steps are reversible (Hoskins et al. 2011). Colocalization single-molecule
spectroscopy (CoSMoS) experiments use fluorescently tagged snRNPs and pre-
mRNAs to follow spliceosome assembly in real time. These experiments revealed
that spliceosome components could engage and dissociate from a pre-mRNA mul-
tiple times before splicing. In fact, further CoSMoS analysis demonstrated that
early complex (i.e., prespliceosomes) formation occurs in a branched pathway of
U1 or U2 snRNP recruitment (Figure 3.1; Shcherbakova et al. 2013). Though
there does appear to be some level of commitment as pre-mRNAs associated with
late stage spliceosome were more likely to complete the splicing cycle (Hoskins et
al. 2011). Reversal of late stage spliceosomes suggests that regulation of splice site
choice may occur much later in the assembly pathway than previously thought.
To observe alternative splicing choices on a transcriptome-wide scale, current anal-



























Figure 3.1: Schematic of the spliceosome assembly cycle showing the stepwise composition of
snRNP(s) and RNA within each discrete spliceosomal complex. Updated version of Figure 1.3 reflect-
ing assembly reversibility determined by CoSMoS experiments. Figure adapted from Shcherbakova
et al. 2013. Copyright 2013 Elsevier.
contain evidence of final splicing choices. As such, evidence of reversed spliceo-
some assembly (and the resulting spliced intermediates) is lost. Recently, Chen
et al. demonstrated that intron-lariat-containing complexes from the genetically
tractable fission yeast are stable during tandem affinity purifications (Chen et
al. 2014). By mapping the excised introns to their genomic locations, the au-
thors were able to visualize spliceosome occupancy transcriptome-wide and iden-
tify more than a hundred previously unannotated yeast introns. Later dubbed
“spliceosome profiling,” this technique was modified to include a number of other
sequencing methods (Figure 3.2; Chen et al. 2018). This allowed the authors to
better globally map splice site and branch point locations (Figure 3.3), and led to
the identification of hundreds of new introns.
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Figure 3.2: Schematic of 5’-P, 3’-OH, spliceosome RNA-seq, and spliceosome footprint libraries
constructed to identify the footprint of intron lariat spliceosome complexes in S. pombe. 5’-P and 3’-
OH libraries mark intronic boundaries; spliceosome RNA-seq libraries cover the entire intron whereas
spliceosome footprinting protects only RNA within the isolated complex. Figure from Chen et al.
2018. Copyright 2018 Elsevier.
In this chapter, I present the initial findings from activated spliceosomes isolated
from the nuclear fraction of HEK293 cells using RIPiT-Seq. These findings will
be compared to both a control RIPiT-Seq targeting the exon junction complex
(EJC; Section 1.1.3) and cytoplasmic RNA-Seq. Although this project was not
completed, the data contained within this chapter illustrate the potential for foot-
printing mammalian spliceosomes transcriptome-wide using RIPiT-Seq.
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Figure 3.3: Genome browser tracks of library coverage across individual genes containing one (top),
two (middle), or multiple (bottom) annotated introns. SPAC1638.01c also contains a previously
unannotated intron. Figure from Chen et al. 2018. Copyright 2018 Elsevier.
3.3 Results
3.3.1 Isolating late-stage activated spliceosomes
In a previous study from the Moore lab that examined footprints of the EJC
transcriptome-wide (Singh et al. 2012), components of the spliceosome were ob-
served via mass spectrometry in the elution of single immunoprecipitations (IPs)
targeting two different core EJC components (Figure 3.4, left). This result was
somewhat expected as the EJC associates with the activated spliceosome complex
during, and subsequent to, the first step of splicing (Section 1.3.1). Due to the dy-
namics of the spliceosome’s composition, however, it was uncertain whether these
interactions were sufficient to preserve assembly of the spliceosome during experi-
mentation. Fortunately, the mass spec analysis suggested that the EJC RIPiT-Seq
strategy could be adapted to isolate spliceosomes by targeting a spliceosomal pro-
tein in the second IP (Figure 3.4, right).
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Figure 3.4: (A) Proteins (left) that co-purify with core EJC machinery after immunoprecipitation
of FLAG-eIF4AII or FLAG-Magoh. Heat map (center) indicates fold enrichment of each protein
compared to a control FLAG-only IP. Protein stoichiometries relative to RBM10 compared between
each IP (right). Dashed line shows levels of copurified coe EJC proteins (blue, level of Y14 and
Magoh in FLAG-eIF4AIII IP; red, level of eIF4AII in FLAG-Magoh IP.). (B) Schematic of RIPiT-Seq
strategy to specifically purify activated spliceosome complexes. Spliceosome and core EJC proteins,
colored; exonic RNA sequence, black line; intronic RNA sequence, dashed line. Figure adapted from
Singh et al. 2012. Copyright 2012 Elsevier.
The modified RIPiT-Seq protocol (Figure 3.4, right) used for the experimentation
described below can be found in detail in Section 3.5. In addition to the antibody
change during the second IP, we also altered this protocol in two ways to further
enrich for spliceosomes. First, we treated HEK293 cells with digitonin, a deter-
gent that can permeabilize the plasma membrane but not the nuclear membrane.
We then discarded the resulting cytoplasmic supernatant, including EJC-bound
cytoplasmic mRNAs. Second, we treated the isolated nuclei with formaldehyde
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to chemically crosslink RNAs and proteins. Crosslinking prevents protein dis-
sociation and reassociation events during cell lysis and IP and had previously
proven beneficial to mapping binding sites of other RNA-binding proteins (e.g.,
Staufen1) transcriptome-wide using RIPiT-Seq (Ricci et al. 2014; Singh et al.
2014). Whereas the EJC very stably binds to an mRNA and can maintain these
interactions under native conditions throughout RIPiT-Seq, associations within
the spliceosome and between the spliceosome and its pre-mRNA substrate are
much more transient. Thus, we collected input material for spliceosome RIPiT-
Seq experiments from nuclei treated both with or without formaldehyde.
Spliceosomes containing FLAG-tagged Magoh, a core EJC component, within this
material were then immunoprecipitated using anti-FLAG beads. While on the
beads, we fragmented associated RNA using a limited RNase T1 digestion. This
deviates from the RNase 1 treatment in the RIPiT-Seq protocol described previ-
ously (Singh et al. 2014) as RNase T1 cleavage is restricted to guanine residues
on single stranded RNA, thus leaving uridine-rich snRNAs mostly intact. Once
eluted from the FLAG beads, we then mixed the immunoprecipitated material
with beads conjugated to either anti-Prp19 or anti-IBP160. Both proteins are
known components of late-stage activated spliceosomes (Figure 1.4). Prp19 is the
namesake component of the nineteen complex (NTC), which joins the spliceosome
prior to catalytic activation (reviewed in Wahl et al. 2009). IBP160 (KIAA0560)
is a SF1 RNA helicase recruited to the spliceosomal C1 complex by components of
the U2 snRNP. Material eluted from this second IP was then used for subsequent
analysis.
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3.3.2 Differences between EJC and spliceosome RIPiT-
Seq
As the first IP in the spliceosome RIPiT-Seq strategy still targeted a core com-
ponent of the EJC, it was uncertain whether changing the second IP would be
sufficient to isolate a different macromolecular complex. To test whether this
modified protocol successfully enriched for spliceosomes, we compared proteins in
the final eluate to a single FLAG IP targeting FLAG-Magoh and an input con-
trol (Figure 3.5, right). The Western revealed that the second IP targeting the
spliceosome enriched for components of the U2 and U5 snRNPs, the C complex,
and the NTC in the eluted material, whereas most EJC components were partially
lost. Moreover, denaturing PAGE gels showed distinct length differences between
the RNA footprints of the EJC (Figure 3.6, A, lane 2) and the spliceosome (A,
lane 3). The distribution of RNAs protected by the EJC contained both a shorter
footprint attributable to a single EJC and a longer one from EJC multimers,
corroborating previous data (Singh et al. 2012). However, the smear of RNAs
in the spliceosome RIPiT-Seq sample demonstrated that the isolated complexes
were different. Furthermore, this distribution remained the same across different
spliceosome RIPiT-Seq samples (Figure 3.6, B). Collectively, this data confirmed
that this modified version of RIPiT-Seq did in fact selectively target late-stage
activated spliceosomes.
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Figure 3.5: Purification of activated spliceosomal complexes using a RIPiT-Seq strategy targeting
FLAG-Magoh followed by Prp19, a component of the Nineteen Complex (Section 1.1). Spliceosomal
proteins are enriched in the tandem IP (right lane) compared to single FLAG-Magoh IP (center lane).
Data courtesy of Guramrit Singh, PhD.
3.3.3 Composition of spliceosome RIPiT-Seq libraries
RNAs corresponding to spliceosome footprints were isolated from four different
RIPiT-Seq experiments (Table 3.1), size selected between 30 and 80 nts, and
sequenced after preparation using a library protocol developed by our lab (Heyer
et al. 2015). The resulting sequenced libraries ranged in depth between 8 and
36 million reads. In the following analysis, we compared these libraries at times
to previously published EJC RIPiT-Seq and cytoplasmic RNA-Seq libraries to
identify footprints specific to the spliceosome (Singh et al. 2012; Ricci et al. 2014).
Prior to alignment to the genome, we first filtered out rRNA, snRNA and repeat
mapping reads. Although ribosomal RNA made up approximately half of our
uncrosslinked libraries, formaldehyde crosslinking and more stringent wash condi-
tions reduced the amount of contaminating rRNA (Figure 3.7, left). As expected,
snRNAs were much more abundant in the spliceosome RIPiT-Seq libraries than
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Figure 3.6: (A) Comparison of the length distribution of RNase T1-resistant footprints isolated from
EJC (lane 2) or activated spliceosome (lane 3) RIPiTs. Included is a control RIPiT-Seq targeting
a protein that does not associate with the EJC or spliceosome, PHGDH. Immunoprecipitated RNA
fragments were 5’ end labeled then separated by denaturing PAGE. (B) Comparison of the length
distribution of RNase T1-resistant footprints isolated from activated spliceosome RIPiTs (lanes 2-3).
The primary antibody used during the second IP step was varied between experiments to target differ-
ent spliceosome complexes. Immunoprecipitated RNA fragments were 5’ end labeled then separated
by denaturing PAGE. Data courtesy of Guramrit Singh, PhD.
Table 3.1: Sequencing and alignment information for activated spliceosome RIPiT-Seq libraries.
in cytoplasmic RNA-Seq regardless of crosslinking treatment. Moreover, we iden-
tified differences in the distribution of snRNA species between the two library
types. U1 snRNA predominated in RNA-Seq libraries, likely due to its splicing-
independent function in preventing premature mRNA cleavage and polyadenyla-
tion (Kaida et al. 2010). However, late stage spliceosomes contain U2, U5, and
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U6 snRNPs after release of U1 and U4 snRNPs (Section 1.1.2); the snRNA read
distribution in RIPiT-Seq libraries reflects this composition (Figure 3.7, right).
Figure 3.7: Classification of RNA footprints protected by spliceosome complexes. Bar graphs show
fraction of mapped reads sorted by classes of RNA (left) or snRNAs (right).
The remaining reads were then mapped to hg19/GRCh37 using STAR with a low
threshold for mismatched and gapped (i.e., insertions or deletions) alignments to
increase mapping accuracy. We chose STAR as its two-pass alignment method,
in which novel splice junctions are observed in the first pass and then used as
annotation in the second, is ideal for discovering new exon ligation events (Dobin
et al. 2013). Using this alignment tool, we aligned between 8 and 30 million reads
in the spliceosome RIPiT-Seq libraries to the genome (Table 3.1).
Although we targeted different proteins in our second IP, both RIPiT-Seq strate-
gies should isolate the same spliceosome complex and, therefore, should have
(nearly) identical footprints across mRNA species. To investigate this, we first
quantified the level of each mRNA species in the four libraries by calculating their
reads per million (RPM) then normalizing to total mapped reads (Figure 3.8).
Spliceosome-protected mRNAs were found in similar quantities when using the
same antibody in the second IP with or without crosslinking (Figure 3.8A and B).
However, coverage was even more equal in abundance when experiments were per-
formed under crosslinked conditions regardless of antibody choice (Figure 3.8C).
Overall, these results further confirmed that we had isolated the same late-stage
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spliceosome complex using both RIPiT-Seq strategies.
Figure 3.8: Scatterplots comparing reads per million (RPM) between indicated spliceosome RIPiT-
Seq libaries. Comparisons are made between RIPiTs performed under native or crosslinked conditions
(left) or between crosslinked RIPiTs selecting for different proteins in the second IP (right). R:
Pearson’s correlation.
3.3.4 Activated spliceosome footprints transcriptome-
wide
Next, using the UCSC Genome Browser (Kent et al. 2002; Raney et al. 2014),
we explored our data on a gene-by-gene basis across the transcriptome. To iden-
tify footprints specific to the activated spliceosome, we compared our libraries
to both EJC RIPiT-Seq and cytoplasmic RNA-Seq. As expected, reads in the
RNA-Seq library mapped almost exclusively to exons (Figure 3.9, black), and
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the EJC (red) primarily bound a short region located ~24 nt upstream of the
5′ exon (Section 1.1.3; Singh et al. 2012). Based on earlier analysis of the S.
pombe intron lariat complex (Figure 3.3), we anticipated that the footprint of the
mammalian spliceosome would also cover intronic regions. However, this is not
what we found. Instead, the activated spliceosome predominantly protected exons
and splice sites (Figure 3.9, purple and grey). Notably, the intronic signal in-
creased with crosslinking treatment, suggesting chemical crosslinks are necessary
to maintain these interactions (Figure 3.9, bottom).
Figure 3.9: Distribution of mapped reads in EJC (red) and spliceosome RIPiT-Seq (grey, purple)
libraries under native of crosslinked (XL) conditions. Crosslinking better maintains interactions be-
tween the spliceosome and intronic RNA, shown here across the GNB2L1 gene and its final intron
(zoomed).
Further exploration across the transcriptome revealed variations in the splicing
events recorded by spliceosome RIPiT-Seq and cytoplasmic RNA-Seq. One such
example was found in the major and minor isoforms of PKM, which differ based on
mutually exclusive exons 9 and 10 (Figure 3.10, bottom). Although we found little
evidence of the minor isoform in RNA-Seq, this transcript was found in near equal
abundance to the major isoform in crosslinked spliceosome RIPiT-Seq libraries
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(Figure 3.10A). This suggested that this isoform was indeed spliced in HEK293
cells, but degraded before it could be captured by cytoplasmic RNA-Seq.
Figure 3.10: Comparison of coverage across the major and minor isoforms of PKM. Colors and labels
as described for Figure 3.10.
3.3.5 Lack of evidence of “unannotated” splicing
events
Based on this result, we sought out additional evidence of splicing events that
eluded RNA-Seq. As transcriptome annotations are largely based on data from
RNA-Seq experiments (Section 1.5), we suspected that these splicing events may
even be missing from our annotation files. Fortuitously, the combination of EJC
and spliceosome footprints highlighted exon junctions (Figure 3.9). Thus, we
searched for potential introns by looking for areas with a reduced signal in spliceo-
some libraries that were preceded by an EJC footprint upstream in the 5′ exon.
Based on this pattern, we believed we identified such a previously unannotated
intron in the 3′ UTR of hnRNPA2B1 (Figure 3.11). We confirmed this by exam-
ining sequences at the potential novel 5′ and 3′ splice sites and found they were
similar to the consensus sequences (Figure 3.11, bottom). However, at this time,
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our transcriptome was based entirely ons the RefSeq annotation (Section 1.5.1)
and did not contain every previously annotated junction (Figure 1.15). In fact,
further examination of annotated transcriptomes revealed this splicing event was
previously documented in the ENSEMBL database as an NMD isoform (Section
1.5.2; Cunningham et al. 2019).
Figure 3.11: Evidence of potentially unannotated splicing events in EJC and spliceosome RIPiT-Seq
libraries, shown here in the 3’ UTR of hnRNPA2B1. Predicted transcript later identified as an NMD
isoform unannotated in the RefSeq database. Colors and labels as described for Figure 3.10.
3.4 Discussion
It was at this time that we developed the pipeline to identify novel splicing events
(Figure 2.9) and processed the spliceosome RIPiT-Seq libraries. Unfortunately,
due to the shallow sequencing depth and lack of replicates, we were unable to
find substantial evidence of unannotated splicing events in these libraries. Further
attempts to construct similar libraries failed due to a number of issues (data
not shown). Additional cell lines containing FLAG-tagged spliceosome proteins
were later constructed to circumvent these problems (Appendix), but additional
libraries could not be made before the Moore lab shut down. Thus, we switched to
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analyzing these events in EJC RIPiT-Seq libraries that had since been generated
in the lab (Chapter 2).
However, there was still much to be gained from this project. We demonstrated
that it was possible to isolate late-stage spliceosomes from an established cell line
by swapping antibodies used during RIPiT-Seq (Figure 3.4). With one rather
inexpensive change, we could either isolate spliceosomes or the EJC (Figures 3.5
and 3.6). It also confirmed that interactions within the spliceosome or between
the complex and its pre-mRNA substrate were maintained throughout the RIPiT-
Seq protocol. Furthermore, we could compare these libraries with EJC RIPiT-
Seq and cytoplasmic RNA-Seq libraries to identify true isoform expression prior
to cytoplasmic changes (Figure 3.10 and 3.11). This significantly influenced the
analysis we later performed when examining the pre-translational transcriptome
(Chapter 2).
Unlike S. pombe (Figure 3.3), footprints of the mammalian spliceosome predomi-
nantly fell within exonic regions. This result was unexpected and further experi-
mentation is necessary to adequately explain it. However, previous visualization of
the spliceosome could provide some insight. In early electron micrograph images,
large intron loops are visible during co-transcriptional splicing (Proudfoot 2000).
These unbound introns are exposed to RNase T1 during the first IP of spliceo-
some RIPiT-Seq and likely lost during this step. More recently, Zhang et al.
have reported the structure of human activated spliceosomes using cryo-electron
microscopy (Zhang et al. 2017, 2019). These structures supported minimal inter-
actions between the spliceosome and intronic sequences outside of a small portion
of the lariat structure (Zhang et al. 2019). Neither fully explains why we see
such a strong exonic signal, even across very long exonic regions (i.e., 3′ UTRs
as in Figure 3.11). Intronic coverage did improve with formaldehyde crosslink-
ing, suggesting this treatment during RIPiT-Seq is necessary for isolating intact
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spliceosomes much like Staufen1 (Ricci et al. 2014).
Ideally, we would have further modified the RIPiT-Seq strategy to isolate other
spliceosome complexes to identify whether earlier (i.e., A complex) or later (i.e.,
intron lariat complex) complexes had similar footprints or if they behaved more
like S. pombe spliceosomes (Figure 3.3). Specifically, analysis of earlier stage
spliceosome footprints would have allowed us to investigate how far spliceosome
assembly progresses at unused splice sites transcriptome-wide. According to the
commitment model, spliceosomes should only occupy sites used in mature tran-
scripts. However, results from single molecule experiments suggest that early com-
plexes frequently assemble without leading to splicing, thus the majority of splice
sites should be occupied at some time by early stage spliceosomes. By tracking
spliceosome occupation and release of pre-mRNAs at discrete stages throughout
the assembly cycle, we could discriminate between these models.
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3.6 Methods
3.6.1 Spliceosome RIPiT-Seq from crosslinked HEK293
nuclei
All volumes are for one 150mm plate. Scale-up for more plates.
Before RIPiT-Seq experiment:
1. Grow Flp-In FLAG-tagged cells in a 150mm plate to 80-90% confluency in
DMEM media.
2. Induce cells with Tet – 25 ng/mL for FLAG-Magoh for 16-20 hours. Combine
10 uL with 1 mL DMEM media, and then add 62.5 uL per plate.
Washing of HEK Cells:
3. Rinse cells twice with 15 mL ice-cold 1X PBS. For multiple plates: keeps
plates with PBS on ice while washing others.
4. Use cell scraper to remove cells from plate. Resuspend cells in ice-cold 1X
PBS. Collect cells in 50 mL tube.
5. Pellet cells at 500 x g for 5-10 min at 4°C. Remove supernatant.
Preparation and Crosslinking of Nuclei:
6. Resuspend cells in 3 mL ice-cold RSB-100 w/ Digitonin (40 ug/mL).
7. Incubate for 5 min on ice.
8. Pellet nuclei at 2000 x g for 8 min at 4°C. Collect supernatant (cytoplasmic
fraction), as much as wanted for analysis.
9. Resuspend nuclei in 10 mL ice-cold 1X PBS per plate.
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10. Add 0.1% formaldehyde (27 uL of 37% stock solution) to conical and nutate
for 10 min at RT.
11. Add 1 mL quenching buffer and nutate for 5 min at RT.
12. Pellet crosslinked nuclei at 500 x g for 5 min at 4°C.
Preparation of Nuclear Lysate: 13. Resuspend cells in 3 mL ice-cold CLIP Lysis
Buffer. Transfer to 5 mL Eppendorf tube. 14. Incubate extract for 10 min on
ice. 15. Disrupt the extract by sonicating at 40% amplitude using a Microtip for
8 second pulses per plate (separated by 10 second breaks). 16. Transfer sonicated
material to conical and bring up volume with CLIP Lysis Buffer to 3 mL per
plate. Combine all material; use 50 mL conical if using more than 3 (if 150mm)
plates. 17. Spin at 15,000 x g for 10 min at 4°C. (Supernatant = lysate, pellet =
chromatin.) Transfer supernatant to new tube. Transfer 50 uL of supernatant to
1.5 mL Eppendorf tube (input) and freeze for analysis. Resuspend pellet in 100
uL ice-cold 1X PBS and freeze for analysis.
FLAG Immunoprecipitation:
15. Before beginning, wash anti-FLAG agarose beads (250 uL per plate) twice
with 1 mL of Isotonic Wash Buffer (IsoWB). After the first wash, transfer
to conical (same size as step 16).
16. Transfer lysate (supernatant) to conical with beads.
17. Nutate for 1 hour at 4°C.
18. Pellet beads at 400 x g for 1 min at 4°C. Transfer 50 uL of supernatant to
1.5 mL Eppendorf tube (anti-FLAG depletion).
19. Wash beads four times with ice-cold IsoWB using 3 mL per plate.
20. Resuspend beads in 1 mL ice-cold IsoWB and transfer to a 1.5 mL Eppen-
dorf.
21. Pellet beads at 400 x g for 1 min at 4°C. Remove supernatant.
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22. Resuspend beads in ice-cold IsoWB (125 uL per plate) with 10 U/uL RNase
T1 (stock: 1000U/uL, use 10 uL per 1 mL IsoWB).
23. Incubate cells on Thermomixer with intermittent shaking (30 seconds shak-
ing at 1000 rpm with 2 min breaks) for 10 min at 37°C. After RNase treat-
ment, transfer to conical (same size as step 13) in 1 mL ice-cold IsoWB.
24. Wash beads four times with ice-cold IsoWB using 3 mL per plate.
25. Resuspend beads in 1 mL ice-cold IsoWB and transfer to a 1.5 mL Eppen-
dorf.
26. Pellet beads at 400 x g for 1 min at 4°C. Remove supernatant.
27. Resuspend beads in ice-cold IsoWB (125 uL per plate) with 250 ug/mL
FLAG peptide (stock: 5 mg/mL).
28. Elute by gentle shaking for 1.5 to 2 hours at 4°C. Transfer 40 uL (2 x 1/6th
of plate) of eluate to 1.5 mL Eppendorf tube (FLAG elution).
29. To the beads, add 900 uL ice-cold IsoWB, mix with beads, then pellet beads
at 400 x g for 1 min at 4°C. Combine this supernatant with previous elutions
in 2 mL Eppendorf.
Specific Antibody Immunoprecipitation:
30. Before beginning, conjugate antibody to Protein A/G Dynabeads.
31. Add eluate to conjugated beads.
32. Nutate for 2 hours at 4°C.
33. Wash beads four times with 1 mL ice-cold IsoWB.
34. Resuspend beads in 500 uL ice-cold IsoWB and transfer to new 2 mL Ep-
pendorf.
35. Wash beads four times with 1 mL ice-cold IsoWB. Remove supernatant.
36. Add 7 uL Clear Sample Buffer.
37. Incubate beads in buffer for 5 min at RT and then heat for 5 min at 95°C.
Before moving to 95°C, pipette sample to mix.
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38. Capture beads on magnet and transfer supernatant (final elution) to 1.5 mL
Eppendorf. Keep at -20°C. Transfer 2 uL to separate 1.5 mL Eppendorf
(final elution).
RNA Extraction:
39. To reverse crosslinks, heat sample for 45 min at 70°C. Bring up volume of
eluate to 100 uL with H2O.
40. Extract twice with P/C/IAA (pH 4.5) and once with C/IAA.
41. Add 10 g glycogen, 0.1 X volume 3M sodium acetate pH 5.2, and three
volumes of 100% ethanol.
42. Precipitate overnight at -20°C.
43. Pellet RNA at 13000 x g for 30 min at 4°C.
44. Wash once with 70% ethanol.
45. Resuspend RNA in 20 uL. Use 1 uL to quantify RNA, save remaining RNA
for debranching and/or library prep.
Required Buffers
Keep the following buffers at 4°C:
1X PBST Buffer (4°C) Final Concentration
PBS 1X
Tween20 0.02%





CLIP Lysis Buffer (4°C) Final Concentration
NP-40 0.5%
Isotonic Wash Buffer (4°C) Final Concentration
Tris-HCl pH 7.5 20 mM
NaCl 150 mM
NP-40 0.5%
Keep the following buffers at room temperature:
Quenching Buffer (RT) Final Concentration
Glycine 2M
Tris-HCl pH 7.0 25 mM
Clear Sample Buffer (RT) Final Concentration
Tris-HCl pH 6.8 100 mM
SDS 4.0%
EDTA 10 mM
DTT (add fresh) 100 mM
3.6.2 Deep sequencing libraries
EJC RIPiT-Seq and cytoplasmic RNA-Seq libraries were downloaded from
the NCBI GEO GSE41154 (specifically, samples GSM1009416, GSM1009417,
GSM1009418, and GSM1009421).
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Spliceosome RIPiT-Seq libraries were generated from 30-80 nt fragments by 3′
adaptor ligation and reverse transcription. Single-end sequencing (100 nt reads)
on the Illumina ___ platform resulted in 10 to 36 million reads per library (Table
3.1).
3.6.3 Library processing and alignment
Read counts for unprocessed libraries and for the individual processing steps de-
tailed below are provided in Figure 3.1. Prior to alignment, adaptor sequences and
long stretches (≥ 20 nt) of adenosines were trimmed from the 3′ end of sequencing
reads. Spliceosome RIPiT-Seq and cytoplasmic RNA-Seq libraries were filtered
using STAR v2.5.3a (Dobin et al. 2013) for reads that aligned to repeat regions,
as defined by RepeatMasker. Remaining reads were then aligned with STAR on
two-pass mode to the human genome, release hg19/GRCh37 (Dobin et al. 2013).
3.6.4 Plotting and data visualization
Data visualization was performed in R using the ggplot2 software package. The
UCSC Genome Browser was used to view sequencing library tracks and for tran-




4.1 Analysis of the pre-translational transcriptome
The work presented in Chapter 2 encompasses our detailed analysis of the pre-
translational transcriptome in comparison to whole cell and cytoplasmic RNA-
Seq. Though RNA-Seq is often used to evaluate differential gene expression, we
found that EJC RIPiT-Seq better captured AS-NMD isoforms prior to translation-
dependent decay. This provides a better picture of the flux through alternative
processing pathways in mammalian cells. Furthermore, our examination of these
libraries also revealed evolutionarily conserved splicing events absent from previous
RNA-Seq-based annotations.
4.1.1 Flux observed in the pre-translation transcrip-
tome
During the late 2000s, RNA-Seq emerged as the preferred method for evaluat-
ing differential gene expression on a global scale. This method provides a static
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snapshot of the transcriptome, reflecting the intersection between the rate of tran-
scription and decay for each mRNA. However, decay rates are not universal; an
ever-increasing portion of the transcriptome has been annotated as substrates of
rapid turnover through translation-dependent quality control pathways (Section
1.4). Over time, many of these transcripts have been shown to have important
roles in post-transcriptional regulatory processes in higher eukaryotes.
Unfortunately, such isoforms are often lost in RNA-Seq samples of wild-type cells
due to their increased degradation rate. To circumvent this issue, previous RNA-
Seq-based studies have abrogated either translation or the responsible degradation
pathway by treating cells with small molecule inhibitors, antibiotics, or siRNAs
(Section 1.6). Unfortunately, these methods affect more than the intended target
and cause confounding pleiotropic effects. For example, commonly used transla-
tional inhibitors activate a number of signaling pathways within an hour, some-
times less (Sidhu & Omiecinski 1998). Long-term exposure, as is required for
siRNA-mediated knockdown of NMD factors, can be even more severe; within 48
hours of inhibiting NMD, cell death markedly increases (Wengrod et al. 2013).
Thus, gene expression measured following any of these treatments is marred to an
unknown degree by the TDD-independent changes.
Therefore in an effort to better observe TDD-regulated transcripts without these
effects, we turned to previously published EJC RIPiT-Seq libraries (Metkar et al.
2018). This isolation technique captures the mRNA population that has completed
splicing but not yet been translated (as EJCs are removed in the process, Section
1.1.3), effectively eliminating the impact of translation-dependent decay in wild
type cells. A previous analysis of the EJC-bound mRNAs revealed increased occu-
pancy on AS-NMD transcripts (Section 1.7.2; Singh et al. 2012), suggesting this
method could be ideal for studying this specific fraction of the transcriptome. In
fact, our comparison of these libraries to both whole cell and cytoplasmic RNA-Seq
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(Figure 2.1) revealed EJC RIPiT-Seq improved the isolation of mRNAs destined
for translation-dependent decay (Figures 2.3, Figure 2.6B, and 2.7). Furthermore,
enrichment was not restricted to this class of transcripts; untranslated, yet spliced,
RNAs (e.g., XIST) were also up-regulated in EJC RIPiT-Seq libraries (Figure 2.8).
However, the analysis performed thus far relied on available transcriptome anno-
tations; as these are largely based on RNA-Seq data (Section 1.7), we questioned
whether the EJC RIPiT-Seq data contained evidence of mRNAs that eluded this
method of detection. To investigate this possibility, we created a bioinformatics
pipeline to sequester junction-spanning reads that do not align to previously anno-
tated splicing events (Figure 2.9). As there is some degree of variability between
sources (Section 1.5), it was necessary for us to first consolidate annotations from
four sources (RefSeq, Section 1.5.1; Ensembl and GENCODE, Section 1.5.2; and
CHESS, Section 1.5.3) into a single database of almost 600,000 unique intronic
locations. Reads that aligned elsewhere and passed our filtering steps (Figure 2.9)
were then classified as originating from unannotated junctions. Though the vast
majority of annotated junctions appeared in all three libraries (Figure 2.10B, left),
we discovered more than five thousand previously unannotated junctions of which
~68% were present in only EJC RIPiT-Seq libraries (Figure 2.10B, right).
Nonetheless, not all mRNAs in the cell have functional relevance (Section 1.2.1.2)
and some are simply the result of aberrant splicing events, or “splicing noise.” As
previous RNA-Seq-based analysis suggested that upwards of 0.7% of the transcrip-
tome is attributable to such events (Pickrell et al. 2010), we recognized the need
to further filter our newly identified junctions. Therefore, we evaluated the an-
notated and unannotated splice sites used in any of the three libraries based on
conservation and MaxENT scores (Figure 2.13). We then focused on unannotated
events that scored better than 95% of randomly selected sequences that otherwise
mimicked splice sites (i.e., AG/GT dinucleotides at the expected positions; Figure
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2.14A and 2.16A). Using this cut-off, we identified nearly 1000 evolutionarily-
conserved unannotated 5′ and 3′ splice sites (Figure 2.14B). By examining these
highly conserved events individually, we found a number of AS-NMD isoforms
resulting from alternative 5′ and 3′ splice sites (Figure 2.15 and 2.17) or novel
cassette exons (Figures 2.20 and 2.21).
4.1.2 Limitations of relying on previously published
data
Although our analysis of the pre-translational transcriptome proved quite fruitful,
the comparison to whole cell and cytoplasmic RNA-Seq libraries was not without
flaws. Unfortunately, outside factors necessitated our reliance on the previously
published datasets. Based on our initial findings in spliceosome RIPiT-Seq de-
scribed in Chapter 3, we believed that the EJC RIPiT-Seq libraries prepared by
Metkar et al. could provide additional insight about the mammalian transcrip-
tome (Metkar et al. 2018). However, these datasets served as a control to new
methodology in this publication, eliminating the need for traditional RNA-Seq.
Thus, we searched through the literature for potential candidates. We chose the
whole cell and cytoplasmic RNA-Seq libraries from the Yaspo lab based on their
depth, reproducibility between replicates, and the similarities to the preparation
of EJC RIPiT-Seq libraries.
In spite of that, differences between these libraries may affect the quality of this
analysis and should be considered. One such disparity is introduced early in the
EJC RIPiT-Seq protocol (Metkar et al. 2018). Prior to lysis, cells are treated
for an hour with harringtonine, an antibiotic that blocks ribosome translocation.
This elongation inhibitor prevents ribosomes from stripping EJCs from mRNAs
during the pioneer round of translation (Section 1.1.3.2), leading to the accumu-
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lation of transcripts bound by pre-translational RNPs. Though necessary for this
methodology, this treatment muddies our analysis. As a consequence of inhibiting
translation, translation-dependent decay pathways (Section 1.4) are also inhibited.
Thus, we cannot discern whether the enrichment of NMD transcripts in the EJC
RIPiT-Seq libraries is due to this or the technique.
Furthermore, a previous study in yeast demonstrated that cycloheximide, a similar
inhibitor, caused a rapid increase in the transcription of ribosome biogenesis genes
(Santos et al. 2019). However, cells used in this analysis were first starved of amino
acids and may not reflect what occurs in mammalian cells under optimal condi-
tions. In fact, Kearse et al. recently found that cycloheximide down-regulated
transcription in HeLa cells after prolonged exposure (24 hours) but had no effect
after a 15 minute treatment (Kearse et al. 2019). Based on these conflicting
results, we are uncertain of what changes may be introduced by translation inhi-
bition in our cells. To eliminate this potential source of contamination, further
experimentation could eliminate this step during EJC RIPiT-Seq or expose cells
to harringtonine before RNA-Seq.
Another major discrepancy between our analyzed libraries is the difference in se-
quenced read length (150 bp vs 51 bp). Though the reads were appropriately sized
for the purposes of both original publications, the longer length of EJC RIPiT-Seq
reads may improve their mapability and introduce bias in downstream analyses.
A previous study found that computationally shortening 100 bp reads to 50 nt had
no discernable influence on calculating differential gene expression (Chhangawala
et al. 2015). However, the authors found that splice site identification worsened
as reads were shortened. These results suggest that our ability to detect more
unannotated splicing events in EJC RIPiT-Seq libraries may be an artifact of
longer reads. We could evaluate the impact this had on our current libraries by
shortening the EJC RIPiT-Seq reads, either to their first 50 nt or into 50 nt sub-
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sections. As either approach would weaken our ability to detect splice sites rather
than improve it, we would be better off sequencing longer RNA-Seq reads.
4.1.3 Future experimentation
Over the past decade, RNA-Seq-based analyses have greatly expanded our knowl-
edge of the pervasiveness of gene regulation via AS-NMD in different species,
tissues, and conditions (Section 1.4.2). However our data suggests that EJC
RIPiT-Seq better captures rapidly degraded transcripts (Figure 2.7), including
many resulting from infrequently used, yet conserved splice sites (Figures 2.10
and 2.11). How many of these events have been missed? How much of the regula-
tory transcriptome remains unknown?
Fortunately the setup for EJC RIPiT-Seq requires only that Magoh, or another
core EJC protein (Section 1.1.3; Singh et al. 2012), be fused to a FLAG epi-
tope tag. Given the recent advances in genetic modifications using CRISPR, we
can now more easily tag these proteins in a variety of cell lines and organisms.
This would allow us to study the pre-translational transcriptome in backgrounds
that are not amenable to other methods of enriching TDD-regulated transcripts.
For example, complete knockouts of NMD factors (i.e., UPF1 and UPF2) render
mice inviable early in embryonic development (reviewed in Nasif et al. 2018). Al-
though the use of conditional knockouts can overcome this issue in some tissues,
others cannot withstand losing these essential proteins. On the other hand, FLAG-
tagging EJC proteins has thus far shown no negative impact on cell viability or
EJC functionality, suggesting we can apply this method without similar issues.
Furthermore, our success with this approach in finding hundreds of novel con-
served splicing events suggests that it may be particularly beneficial to study-
ing transcriptomes of cancerous cells and tissues. The link between cancer and
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widespread changes to pre-mRNA splicing patterns has been well-established (re-
viewed in Climente-González et al. 2017), and the transcriptomes of many cancer-
ous samples have already been catalogued in The Cancer Genome Atlas (TCGA;
Weinstein et al. 2013). Unfortunately, the vast majority of the data in TCGA has
been obtained via exome sequencing methods that only target annotated exonic
regions, omitting unannotated events similar to ones we observed. How can we
treat the unknown? This was less of a concern when developing treatments that
ubiquitously down-regulate NMD, such as small molecules that permit ribosomal
read-through of stop codons (reviewed in Nasif et al. 2018; Nomakuchi et al. 2016).
However such approaches can have innumerable off-target effects on the transcrip-
tome. Thus, recent therapies have instead shifted to gene-specific NMD inhibition
using antisense oligonucleotides (Nomakuchi et al. 2016). As these oligos function
by blocking EJC binding events downstream of known PTCs, more thoroughly
annotated transcriptomes could provide more potential therapeutic targets.
4.2 Late-stage spliceosome occupancy transcriptome-wide
The work contained within Chapter 3 describes our success in modifying the
previously published RIPiT-Seq protocol (Singh et al. 2014) to instead capture
footprints of late-stage mammalian spliceosomes transcriptome-wide (Figures 3.4,
3.5, and 3.6). Though this project remains incomplete, our initial findings demon-
strated that the spliceosome can withstand this isolation method even under native
conditions (Figure 3.1). However, formaldehyde crosslinking did prove impactful.
In fact, we observed better agreement between spliceosome RIPiT-Seq libraries
when crosslinked than when using the same antibody during the second IP (Fig-
ures 3.7 and 3.8). This suggests that many RNA-protein interactions are not
stable enough to survive both IPs, and comparing the two library types to each
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other may allow us to identify sites of unstable interactions.
Still, even with limited data, this project was more than simply a proof-of-concept.
We began our investigation as an attempt to map the sites of spliceosome ac-
tion transcriptome-wide, a feat previously accomplished in S. pombe by our lab
(Chen et al. 2014). Whereas the purified yeast spliceosome had an overwhelm-
ingly intronic footprint (Figure 3.3), we found late-stage spliceosomes predomi-
nantly occupied exons (Figure 3.9). Protection of intronic regions improved upon
crosslinking, suggesting interactions between the spliceosome and this portion of
pre-mRNA substrates is unstable. Fortunately, the exonic bias retained evidence
of flux through alternative splicing (Figure 3.10) and quality control pathways
(Figure 3.11) before these transcripts were removed in the cytoplasm. Though we
did not further investigate these datasets, these observations greatly influenced
the analysis discussed in Chapter 1.
4.2.1 Observing sites of spliceosome action
One area in the field of mRNA splicing that remains largely unanswered is how
and when splicing choices are decided in the cell. Early analyses suggested that
spliceosomes commit to completing the splicing cycle by early complex formation,
once the 5′ and 3′ splice sites have been identified (reviewed in Section 3.2). How-
ever, more recent single molecule experiments have challenged these conclusions
by demonstrating that formation of each subcomplex throughout the assembly
cycle is reversible (Hoskins et al. 2011). Unfortunately, the RNA species used
during these analyses are typically quite short and cannot adequately reflect the
more complex choices encountered in mammalian cells. Thus, our understanding
of such cases would be greatly enhanced by a transcriptome-wide map of interac-
tions between pre-mRNAs and the spliceosome.
129
Results from our initial attempt at creating such a map of mammalian activated
spliceosomes can be split into two categories: the expected and unexpected. Based
on a previous analysis of yeast spliceosomes, we anticipated a strong bias towards
introns (Figure 3.3). This intronic disposition has previously aided the analysis of
functional introns in yeast, allowing Chen et al. to both correct previous misanno-
tations and identify many new ones (Chen et al. 2014, 2018). Though we did not
find a bias to the same extent in the mammalian system, we observed extensive
protection of intronic regions in all library types (Figures 3.9, 3.10, and 3.11).
Furthermore, the yeast spliceosome largely occupied sequences near the intronic
boundaries, particularly in longer introns (Chen et al. 2014, 2018). In agreement
with this finding, recent cryo-EM structures have demonstrated that late-stage
yeast spliceosomes protect 38 nucleotides within the intron - 15 nt downstream
of the 5′ splice site and 23 nt around the branch point (reviewed in Chen et
al. 2018). Comparatively, the structure of activated mammalian spliceosomes
indicates that these complexes bind to 59 nucleotides attributable to the intron
lariat and 5′ exon (Zhang et al. 2017). However, these structures fail to account
for why we often observed spliceosome occupation extending across the full length
of the intron. It does appear that crosslinking and harsher wash conditions may
enrich for protected fragments near the 5′ and 3′ splice sites as well as internally
(Figures 3.9 and 3.10), but further experimentation is necessary to determine the
full impact of this treatment.
Unexpectedly, we found spliceosome occupation of exonic regions to be particularly
resistant to RNase T1 digestion compared to neighboring introns. In fact, exon
coverage further increased under native conditions, suggesting these interactions
between late-stage spliceosomes and exons are incredibly stable (Figures 3.9, 3.10,
and 3.11). This result may be best explained by earlier in vitro experiments that
found increased rates of splicing on multi-intron-containing transcripts (Crabb et
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al. 2010). The authors determined this enhancement resulted from retention of the
spliceosome, specifically the exon definition complex, after successful removal of
nearby introns. Alternatively, it is also possible that the exonic signal could result
from exonic DNA contamination due to continued association between pre-mRNAs
and chromatin until transcripts are fully spliced (Bhatt et al. 2012; Pandya-Jones
et al. 2013). However, both the spliceosome RIPiT-Seq (Section 3.6.1) and library
preparation protocols (Heyer et al. 2015) should prevent us from sequencing such
an impurity. Like the intronic signal, further experimentation and analysis is
needed to understand this pattern of exonic coverage.
One feature apparent in the early analysis of this data is the enhanced coverage
in spliceosome RIPiT-Seq libraries across alternatively spliced transcripts (Figures
3.10 and 3.11). Though regions specific to both of the shown isoforms are occupied
by late-stage spliceosomes, we find little evidence of their existence in cytoplasmic
RNA-Seq. In the case of PKM, the expression pattern of major and minor iso-
forms agrees with RNA-Seq datasets in the TCGA that were constructed from 16
different tumor samples (Desai et al. 2014). Previous studies have suggested the
expression of the minor PKM isoform is downregulated by increased binding of
three hnRNP proteins near this exon (David et al. 2010). Moreover, crosslinked
IPs of hnRNPA2B1 found a similar binding pattern in its own 3′ UTR (Martinez
et al. 2016), where we find increased late-stage spliceosome occupancy (Figure
3.11). If hnRNP proteins suppress spliceosome assembly (Section 1.2.1.3), why
do we see EJC-containing spliceosomes in these regions? Spliceosome occupation
may signify these regulators significantly slow rather than outright prevent assem-
bly or promote the reversal of late-stage assembly before completion of the cycle.
Additional analysis of earlier and later complexes, and comparison to known bind-
ing profiles of other RNA-binding proteins, could help elucidate this method of
regulation.
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4.2.2 Limitations of current spliceosome RIPiT-Seq
strategy
Although we successfully modified the EJC RIPiT-Seq protocol to isolate late-
stage spliceosomes, further experimentation using this exact setup is somewhat
confined in its scope. This is a consequence of relying on a cell line that contains
a FLAG-tagged EJC protein rather than targeting a spliceosomal protein for the
analysis performed in Chapter 3. However, this strategy was the most practical
option at first because it allowed us to begin investigating mammalian spliceosome
footprints without first establishing a new cell line. Unfortunately, by using these
HEK293 cells, only Magoh-containing spliceosomes can be pulled down in the first
IP, which limits the stage at which spliceosomes can be isolated during the second.
Thus, this setup in its current state precludes the option of isolating earlier or
later complexes.
After this project began, other labs since reported the crystal structures of various
human spliceosomal complexes throughout the assembly cycle. These structures
both confirmed the absence of the EJC in the pre-activation B complex (Bertram et
al. 2017) and its release during the formation of the intron lariat structure (Zhang
et al. 2019). Moreover, structures of activated spliceosomes showed that Magoh
and other EJC components bind to the periphery of the spliceosome rather than
near its core (Figure 4.1). In this confirmation, eIF4AII interacts extensively with
the spliceosome, particularly with splicing factors Cwc22 and Snu114, whereas
other core EJC proteins contact only each other and eIF4III. The location of
Magoh in this complex may explain why this particular EJC protein was amenable
to isolating spliceosomes during the RIPiT-Seq protocol.
132
Figure 4.1: Crystal structure of the human C complex spliceosome including three snRNAs (U2, U5,
and U6), the free 5’ exon, the intron lariat, and nearly 50 proteins. RNAs and proteins are color
coded and categorized below by their primary complex association. Figure from Zhang et al. 2017.
Copyright 2017 Elsevier.
Bearing this in mind, these structures could guide us in choosing spliceosomal
proteins that are potentially the most accommodating to epitope tagging. Though
the FLAG tag is a relatively short addition, the fusion of any epitope tag to a
protein of interest could interfere with both binding and/or functionality (reviewed
in Singh et al. 2014). This is particularly important to consider when tagging
spliceosomal proteins as countless protein-protein and protein-RNA interactions
mediate progression through the spliceosome assembly cycle (Section 1.1.2). An
epitope tag that interferes with these required interactions would inhibit splicing
transcriptome-wide and cause a lethal phenotype. Furthermore, even if the tagged
protein behaved normally, spliceosomal components located within the core of the
macromolecular complex are likely inaccessible during IPs. In fact, our success in
spliceosome RIPiT-Seq experiments may be due to the peripheral location of both
Prp19 and IBP160 (a.k.a Aquarius), the two proteins targeted in the second IP,
in Magoh-containing spliceosomes (Figure 4.1). Thus, the ideal candidates when
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creating new FLAG-tagged cell lines are spliceosomal proteins that are similarly
located, that can function in spite of a new tag, and that associate with multiple
complexes throughout assembly. Initial efforts in establishing such cell lines is
included in Appendix 1.
4.2.3 Potential applications of mammalian spliceosome
footprinting
4.2.3.1 Evidence of splicing catalysis
Due to the premature termination of this project, there remains much to be ex-
plored using this methodology concerning spliceosome occupancy and action in
mammalian cells. Splicing of human introns faces a number of complex challenges
that cannot be investigated in the simpler yeast system.
For example, some mammalian introns can be quite long - some even longer than
100,000 nt and littered with cryptic splice sites! Though these sequences may
resemble 5′ and 3′ splice sites, the final mRNA record only reflects a single splicing
event between the extreme ends of the long intron. Is the intron truly removed in
a single event? Or does it occur in piecemeal though the excision of shorter, nested
fragments until the full intron has been spliced? The latter, known as recursive
or nested splicing, was first discovered in Drosophila (Hatton et al. 1998), then
later confirmed to occur during the processing of an 110 kb intron in the human
dystrophin pre-mRNA (Suzuki et al. 2013). As evidence of such events is erased
after the final exon ligation event, how can we identify sites of spliceosome action
transcriptome-wide?
Fortunately, records of spliceosome catalysis are also maintained in the byproduct
of the splicing cycle, the intron lariat. Though the lariat corresponds to the full
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length of an excised intron, regions downstream of the 5′ exon and surrounding
the branch point can both be identified by sequencing reads that transverse the
branched structure. However, this Y-shaped structure impedes reverse transcrip-
tase processivity during RNA-Seq library preparation, causing these reads to be
sequenced very infrequently (Taggart et al. 2012). In previous studies, exten-
sive deep sequencing libraries and methodology tailored to capturing this specific
structure have been used to map branch points transcriptome-wide (Taggart et al.
2012; Mercer et al. 2015). Yet these methods identified less than 20% of previ-
ously annotated introns and showed a propensity towards shorter introns. Thus,
by further modifying spliceosome RIPiT-Seq to isolate lariat-containing complexes
like the work performed by Chen et al. in yeast (Chen et al. 2018), we could both
annotate additional branch point locations and seek evidence of recursive splicing
reactions.
4.2.3.2 Spliceosome assembly at unused splice sites
Although this project was performed in an established HEK293 cell line for rea-
sons outlined in Section 4.2.2, we initially intended to use this methodology to
study alternative splicing (AS) in primary cells or tissues. In these backgrounds,
the expression of many mRNA isoforms is known to occur in a stimulus-dependent
fashion (Eric T. Wang et al. 2008). Specifically, widespread AS events have been
implicated in fine-tuning the innate immune response when either dendritic cells or
macrophages interact with a pathogen (Rodrigues et al. 2013; Wells et al. 2006).
When treated with the Gram-negative bacterial membrane protein lipopolysac-
charide, macrophages activate the NF- B signal transduction pathway (Ma et al.
2003), triggering the expression of dozens of alternatively spliced isoforms (Wells
et al. 2006).
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This provides us with a means of controlling the appearance of specific isoforms,
and therefore the use of specific splice sites. In cases of isoform switching, do
late stage spliceosomes occupy unused sites in unstimulated cells? Pre-assembly
of the early spliceosome complexes would allow faster splice site recognition, and
hence faster immune response. However, when analyzing AS events triggered
by the acute inflammatory response, the Smale and Black labs determined that
constitutive introns splice faster than alternatively spliced cassette exons (Bhatt
et al. 2012). This methodology could not pinpoint which step in assembly causes
this lag. By footprinting spliceosomal complexes throughout the assembly cycle
before and after activation, we can determine whether assembly begins de novo at




components of the mammalian
spliceosome
4.3 Introduction
Although using the previously established EJC-tagged HEK293 cell line for spliceo-
some RIPiT-Seq allowed us to begin the project immediately, we recognized the
limitations imposed by this setup (Section 4.2.2). Thus, while we performed these
experiments, we also created new cell lines by FLAG-tagging components of the
spliceosomal. When we first selected which proteins to tag, the yeast and human
spliceosome cryo-EM structures had not yet been released. As such, we evaluated
candidates based on two criteria. First, we picked proteins that had been pre-
viously immunoprecipitated successfully when fused to FLAG or another epitope
tag. Earlier studies revealed that tags can alter the normal interactions of an RNA
binding protein (Chan et al. 2004; reviewed in Singh et al. 2014); we wanted to
avoid wasting time on such an outcome. Furthermore, we focused on proteins that
allowed us to isolate a variety of complexes. Having demonstrated that modifying
the second IP in RIPiT-Seq was sufficient to isolate either the EJC or spliceosome
from one cell line, we wanted the same flexibility in future experiments. With this
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in mind, we used the available mass spectrometry analysis of discrete spliceosome
complexes (Figure 1.4) to inform our choices.
4.4 Results
Based on these criteria, we selected four ideal candidates for spliceosome RIPiT-
Seq: Prp19, Prp17, TFIP11, and U2A′. In order to express FLAG-tagged versions
of these proteins in HEK293 cells, we used the FLP-In system (Methods). This
transfection method stably integrates an epitope-tagged protein of interest into
the genome under the control of a tetracycline-regulated promoter. An inducible
promoter provides a means of fine-tuning the expression of FLAG-tagged proteins
to match the levels of endogenous copies (data not shown). This is done to ensure
that our experiments more accurately reflect endogenous RNPs.
In total, we created seven new cell lines with one of four tagged spliceosomal
proteins to complement our EJC-tagged cells (Table 4.1).
Table 4.1: Available FLAG-tagged HEK293 cell lines for spliceosome RIPiT-Seq experiments.
Protein Spliceosome Complex Terminus Published in
eIF4AIII B to EJC N Singh et al. 2012
Magoh B to EJC N Singh et al. 2012
Prp19 B* to ILS N
Prp17 C to C* N and C
TFIP11 B to ILS N and C
U2A’ A to C* N and C
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4.6 Methods
4.6.1 FLP-In transfection in HEK293 cells
FLAG-tagged proteins of interest were stably integrated into HEK293 cells using
the FLP-In System available from ThermoFisher Scientific (#K6500-01). Once
established, cells were stored in liquid nitrogen and catalogued.
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